<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer - Roberts, KE - 2020 | Cochrane Library</title> <meta content="Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer - Roberts, KE - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012988.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer - Roberts, KE - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012988.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012988.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer" name="citation_title"/> <meta content="Kate E Roberts" name="citation_author"/> <meta content="kate.roberts@health.qld.gov.au" name="citation_author_email"/> <meta content="Kirsty Rickett" name="citation_author"/> <meta content="UQ/Mater McAuley Library" name="citation_author_institution"/> <meta content="Sophie Feng" name="citation_author"/> <meta content="Mater Misericordiae Ltd" name="citation_author_institution"/> <meta content="Dimitrios Vagenas" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="Natasha E Woodward" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD012988.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/01/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012988.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012988.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012988.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Exercise Therapy [methods]; Aromatase Inhibitors [*adverse effects, therapeutic use]; Breast Neoplasms [drug therapy]; Musculoskeletal Pain [*chemically induced, *prevention &amp; control]; Neoplasm Staging; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012988.pub2&amp;doi=10.1002/14651858.CD012988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012988\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012988\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","hr","fa","fr","ms","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012988.pub2",title:"Exercise therapies for preventing or treating aromatase inhibitor\\u2010induced musculoskeletal symptoms in early breast cancer",firstPublishedDate:"Jan 29, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Breast Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012988.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012988.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012988.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012988.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012988.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012988.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012988.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012988.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012988.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012988.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5368 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012988.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/appendices#CD012988-sec-0114"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/table_n/CD012988StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/table_n/CD012988StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#CD012988-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Kate E Roberts</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#CD012988-cr-0003">Kirsty Rickett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#CD012988-cr-0004">Sophie Feng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#CD012988-cr-0005">Dimitrios Vagenas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information#CD012988-cr-0006">Natasha E Woodward</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information/en#CD012988-sec-0122">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 January 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012988.pub2">https://doi.org/10.1002/14651858.CD012988.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012988-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012988-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012988-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012988-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012988-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012988-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012988-abs-0001" lang="en"> <section id="CD012988-sec-0001"> <h3 class="title" id="CD012988-sec-0001">Background</h3> <p>Survival for stage I to III, hormone receptor‐positive, breast cancer has substantially improved over time due to advances in screening, surgery and adjuvant therapy. However many adjuvant therapies have significant treatment‐related toxicities, which worsen quality of life for breast cancer survivors. Postmenopausal women with hormone receptor‐positive breast cancer are now prescribed aromatase inhibitors (AI) as standard, with longer durations of therapy, up to 10 years, being considered for certain women. AI treatment is associated with a high incidence of AI‐induced musculoskeletal symptoms (AIMSS), often described as symmetrical pain and soreness in the joints, musculoskeletal pain and joint stiffness. AIMSS reduces compliance with AI therapy in up to one half of women undergoing adjuvant AI therapy, potentially compromising breast cancer outcomes. Exercise has been investigated for the prevention and treatment of AIMSS but the effect of this intervention remains unclear. </p> </section> <section id="CD012988-sec-0002"> <h3 class="title" id="CD012988-sec-0002">Objectives</h3> <p>To assess the effects of exercise therapies on the prevention or management of aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS) in women with stage I to III hormone receptor‐positive breast cancer. </p> </section> <section id="CD012988-sec-0003"> <h3 class="title" id="CD012988-sec-0003">Search methods</h3> <p>We searched Cochrane Breast Cancer's Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases up to 13 December 2018. We also searched two conference proceedings portals and two clinical trials registries for ongoing studies or unpublished trials, or both, in August 2019. We also reviewed reference lists of the included studies. </p> </section> <section id="CD012988-sec-0004"> <h3 class="title" id="CD012988-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials that compared exercise versus a comparator arm. We did not impose any restriction on the comparator arm, which could include an alternative type of exercise, no exercise or a waiting list control. Both published and non‐peer‐reviewed studies were eligible. </p> </section> <section id="CD012988-sec-0005"> <h3 class="title" id="CD012988-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data, assessed risk of bias and certainty of the evidence using the GRADE approach. The outcomes investigated were pain, joint stiffness, grip strength, health‐related quality of life, cancer‐specific quality of life, adherence to AI therapy, adverse events, incidence of AIMSS, breast cancer‐specific survival and overall survival. For continuous outcomes that were assessed with the same instrument, we used the mean difference (MD); for those outcomes that used different instruments, we used the standardised mean difference (SMD) for the analysis. For dichotomous outcomes, we reported outcomes as an odds ratio (OR). </p> </section> <section id="CD012988-sec-0006"> <h3 class="title" id="CD012988-sec-0006">Main results</h3> <p>We included seven studies with 400 randomised participants; one study assessed exercise for preventing AIMSS and six studies assessed treating AIMSS. </p> <p>For preventing AIMSS, the single study reported no difference in pain scores, grip strength or compliance to taking AI medication between groups. Data values were not provided in the study and no other outcomes were reported. </p> <p>For managing AIMSS, we found that the evidence for the effect of exercise therapies on overall change in worst pain scores was very uncertain (SMD −0.23, 95% confidence interval (CI) −0.78 to 0.32; 4 studies, 284 women; very low‐certainty evidence). The evidence suggested that exercise therapies result in little to no difference in overall change in stiffness scores (Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) stiffness score MD −0.76, 95% CI −1.67 to 0.15 and Visual Analogues Scale (VAS) stiffness score MD −0.42, 95% CI −2.10 to 1.26; 1 study, 53 women; low‐certainty evidence). The evidence was very uncertain for the outcomes of overall change in grip strength (MD 0.30, 95% CI −0.55 to 1.15; 1 study, 83 women; very low‐certainty evidence); overall change in health‐related quality of life (subscales of SF‐36 tool ranged from least benefit of MD 1.88, 95% CI −2.69 to 6.45 to most benefit of MD 9.70, 95% CI 1.67 to 17.73; 2 studies, 123 women, very low‐certainty evidence); overall change in cancer‐specific quality of life (MD 4.58, 95% CI −0.61 to 9.78; 2 studies, 136 women; very low‐certainty evidence); and adherence to aromatase inhibitors (OR 2.43, 95% CI 0.41 to 14.63; 2 studies, 224 women; very low‐certainty evidence). There were no adverse events identified across four studies in either arm (0 events reported; 4 studies; 331 participants; low‐certainty evidence). There were no data reported on incidence of AIMSS, breast cancer‐specific survival or overall survival. </p> </section> <section id="CD012988-sec-0007"> <h3 class="title" id="CD012988-sec-0007">Authors' conclusions</h3> <p>Given the wide‐ranging benefits of exercise for people affected by cancer, it was surprising that this review provided no clear evidence of benefit for exercise therapies in women with early breast cancer with AIMSS. This review only yielded seven eligible studies with 400 participants, which is likely to have underpowered the findings. The meta‐analysis was challenging due to the considerable heterogeneity amongst the trials, with a wide range of exercise regimens and follow‐up periods. Despite these inconclusive findings, exercise needs to be part of routine care for women with breast cancer due to its wide‐ranging benefits. Future research in this area would be enhanced with further understanding of the mechanism of AIMSS, a single clear definition of the condition, and phase III randomised controlled trials that are adequately powered to test targeted exercise interventions on the key clinical outcomes in this condition. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012988-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012988-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012988-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012988-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012988-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012988-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012988-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012988-abs-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012988-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012988-abs-0003" lang="en"> <h3>Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer </h3> <p><b>What is the aim of this review?</b> </p> <p>Aromatase inhibitors (AI) are a hormonal therapy used to treat a particular type of breast cancer in post‐menopausal women. However, they can cause joint and muscle pain (called aromatase inhibitor‐induced musculoskeletal symptoms, or AIMSS). The aim of this Cochrane Review was to find out whether exercise therapies can reduce this pain in women undergoing treatment for early breast cancer. </p> <p><b>Key messages</b> </p> <p>It is unclear if exercise improves, worsens, or makes no difference to pain, quality of life, grip strength, or the number of women continuing to take AI medication. Exercise likely results in little to no difference in stiffness in women suffering from AIMSS, although the certainty of this evidence was also low. Exercise is probably safe in women with AIMSS. </p> <p><b>What was studied in the review?</b> </p> <p>Studies have shown a survival benefit for women when they take AIs for five to ten years after surgery, but unfortunately, they are associated with musculoskeletal side effects that may cause some women to stop taking their medication, which may have an impact on their survival. We looked at whether exercise could help prevent or treat the joint pains, stiffness and muscle aches from AIs that are being taken by women with breast cancer to prevent a recurrence. We looked at research studies of exercise compared to either usual care, being on a waiting list for an exercise treatment, or another exercise like walking, in women who had AIMSS. Women aged 18 years or older with early stage breast cancer being treated with AI were included. In most studies, the women had to have joint or muscle pains whilst being treated with an AI. </p> <p>We studied a number of outcomes, including changes in pain, stiffness, hand strength (grip strength), the number of women continuing to take AI medication, the quality of life of women on AI medication, and the safety of the exercise programmes. </p> <p><b>What are the main results of the review?</b> </p> <p>We collected and analysed all relevant studies to answer this question and found seven studies with 400 women. The studies included different numbers of women, ranging from 20 to 121 participants. Three studies were conducted in the USA, one study in the UK, one study in Australia, one study in Canada and one study in Japan. Overall, the certainty of the evidence for most outcomes was very low. This may have been because many of the studies did not have many participants, making it hard to find small differences. Other problems were that the women and the people assessing the results, knew which exercise therapy the woman was receiving, and this may have introduced bias. Many studies did not report all of their results, and some of the studies were not carried out to a high research standard. </p> <p>Therefore it is unclear whether exercise has a positive or negative effect on pain, grip strength, the number of women continuing to take AI medication, or the quality of life of women with AIMSS, because of the very low certainty of the evidence. Exercise likely results in little to no change in stiffness in women suffering from AIMSS. Importantly, exercise is probably safe, with no harms reported, although the studies did not follow up the women for very long. There were no data available to assess the effect of exercise on survival in women with AIMSS. Despite these inconclusive findings, exercise should still be recommended as part of routine care for women with breast cancer, due to its wide‐ranging benefits. </p> <p><b>How up to date is this review?</b> </p> <p>The last search for studies in this review was performed in December 2018 and the search for ongoing studies was conducted in August 2019. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012988-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012988-sec-0109"></div> <h3 class="title" id="CD012988-sec-0110">Implications for practice</h3> <section id="CD012988-sec-0110"> <p>Overall, this review highlighted that across multiple outcomes, there was very low‐certainty evidence. This means that we were uncertain of the overall effect of exercise on pain, grip strength, health‐related quality of life, cancer‐specific quality of life or adherence to aromatase inhibitors in the treatment of aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS). There was insufficient evidence to assess the use of exercise in the prevention of AIMSS. </p> <p>Despite these inconclusive findings, exercise still needs to be part of routine care for women with breast cancer. Current guidelines recommend exercise be embedded as part of routine care for women with breast cancer and in fact in all people with cancer (<a href="./references#CD012988-bbs2-0054" title="Clinical Oncology Society of Australia. COSA Position Statement on Exercise in Cancer Care. Sydney: Clinical Oncology Society of Australia, 2018. ">COSA 2018</a>; <a href="./references#CD012988-bbs2-0061" title="European Society for Medical Oncology. ESMO Handbook on Rehabilitation Issues During Cancer Treatment and Follow‐Up. Lugano, Switzerland: European Society for Medical Oncology, 2014. ">European Society for Medical Oncology 2014</a>; <a href="./references#CD012988-bbs2-0107" title="RockCL , DoyleC , Demark‐WahnefriedW , MeyerhardtJ , CourneyaKS , SchwartzAL , et al. Nutrition and physical activity guidelines for cancer survivors. CA: a Cancer Journal for Clinicians2012;62(4):243‐74. ">Rock 2012</a>). Exercise has been shown to be beneficial in relieving cancer fatigue (<a href="./references#CD012988-bbs2-0055" title="CrampF , Byron‐DanielJ . Exercise for the management of cancer‐related fatigue in adults. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD006145.pub3] ">Cramp 2012</a>), and depressive symptoms (<a href="./references#CD012988-bbs2-0101" title="PatsouED , AlexiasGD , AnagnostopoulosFG , KaramouzisMV . Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta‐analysis of randomised control trials. ESMO Open2017;2(5):e000271. ">Patsou 2017</a>), and improving cancer‐related outcomes (<a href="./references#CD012988-bbs2-0053" title="CormieP , ZopfEM , ZhangX , SchmitzKH . The impact of exercise on cancer mortality, recurrence, and treatment‐related adverse effects. Epidemiologic Reviews2017;39(1):71‐92. ">Cormie 2017</a>), and quality of life (<a href="./references#CD012988-bbs2-0069" title="GerritsenJK , VincentAJ . Exercise improves quality of life in patients with cancer: a systematic review and meta‐analysis of randomised controlled trials. British Journal of Sports Medicine2016;50(13):796‐803. ">Gerritsen 2016</a>). Given that a supervised exercise programme has a low risk of harm, it is reasonable to incorporate aerobic and resistance exercise into the treatment of all people affected by cancer. </p> <p>The updated guidelines for physical activity in cancer survivors, led by the Amercian College of Sports Medicine, recommends aerobic and resistance training for approximately 30 minutes, for three sessions per week (<a href="./references#CD012988-bbs2-0049" title="CampbellKL , Winters‐StoneKM , WiskemannJ , MayAM , SchwartzAL , CourneyaKS , et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Medicine and Science in Sports and Exercise2019;51(11):2375‐90. ">Campbell 2019</a>). Despite longstanding guidelines recommending exercise in people with cancer, a review by Irwin (<a href="./references#CD012988-bbs2-0083" title="IrwinML . Physical activity interventions for cancer survivors. British Journal of Sports Medicine2009;43(1):32‐8. ">Irwin 2009</a>), estimated that approximately 70% of cancer survivors were not performing the recommended exercise targets. Lack of adherence constitutes an important barrier to implementation of recommended exercise targets. Similarly, resource constraints may limit the implementation of certain types of exercise interventions studied in AIMSS, and their adoption into practice in certain healthcare systems. In keeping with the previously mentioned guidelines, exercise should continue to be recommended for women with breast cancer undergoing adjuvant AI treatment, although patient preference, lifestyle and health factors, and resource constraints may need to be considered for individual women. </p> </section> <h3 class="title" id="CD012988-sec-0111">Implications for research</h3> <section id="CD012988-sec-0111"> <p>Research in AIMSS has been hampered by a poor understanding of the aetiology of the syndrome (<a href="./references#CD012988-bbs2-0098" title="NiravathP . Aromatase inhibitor‐induced arthralgia: a review. Annals of Oncology2013;24(6):1443‐9. ">Niravath 2013</a>), making it challenging to design and implement trials that address the problem. To sufficiently answer the question of whether exercise can prevent or treat AIMSS, further high‐quality, adequately powered, randomised, phase three controlled trials of targeted exercise interventions on key outcomes would be required. With current guidelines recommending exercise be embedded as part of routine care for women with breast cancer (<a href="./references#CD012988-bbs2-0054" title="Clinical Oncology Society of Australia. COSA Position Statement on Exercise in Cancer Care. Sydney: Clinical Oncology Society of Australia, 2018. ">COSA 2018</a>; <a href="./references#CD012988-bbs2-0061" title="European Society for Medical Oncology. ESMO Handbook on Rehabilitation Issues During Cancer Treatment and Follow‐Up. Lugano, Switzerland: European Society for Medical Oncology, 2014. ">European Society for Medical Oncology 2014</a>; <a href="./references#CD012988-bbs2-0107" title="RockCL , DoyleC , Demark‐WahnefriedW , MeyerhardtJ , CourneyaKS , SchwartzAL , et al. Nutrition and physical activity guidelines for cancer survivors. CA: a Cancer Journal for Clinicians2012;62(4):243‐74. ">Rock 2012</a>), any further exercise trials versus a waiting list control would need to incorporate guideline recommendations appropriate for the local population into the control arm. The control arm should be adequately described in any future or ongoing trials. </p> <p>To improve precision of results, all studies, even if deemed 'negative trials', should endeavour to publish their results, to enable inclusion in future meta‐analyses. </p> <p>Research has been limited also by heterogeneous patient populations (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>). Better understanding of the risk factors for AIMSS may help stratify women who are most at risk of AIMSS (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>). Prior chemotherapy, prior hormone replacement therapy and increased body weight have been identified as increasing the risk of AIMSS (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>). These women may also have the most to benefit from exercise intervention strategies, and research into subgroups who have a higher baseline incidence of AI arthralgia may potentially be a focus for future research. </p> <p>Research in AIMSS has also been hampered by lack of objective outcome measures, the use of multiple different patient‐reported outcomes (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>), and by lack of consensus on the constellation of clinical symptoms and signs that constitute or define the syndrome (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>; <a href="./references#CD012988-bbs2-0098" title="NiravathP . Aromatase inhibitor‐induced arthralgia: a review. Annals of Oncology2013;24(6):1443‐9. ">Niravath 2013</a>). This variability was reflected in the included exercise studies in our review. To reduce clinical and methodological heterogeneity, consensus on definitions and outcome measures in AIMSS needs to be developed as a research priority. Such consensus would improve the ability to answer the relevant research questions. Better definition of AIMSS may lead to more rigorous entry criteria, as it is possible that some of the included studies included participants with pre‐existing musculoskeletal or neuropathic pain syndromes. Patient‐reported outcomes should certainly be the primary focus of AIMSS research, as the most reliable measures of quality of life include patient‐reported outcomes (<a href="./references#CD012988-bbs2-0058" title="DeshpandePR , RajanS , SudeepthiBL , Abdul NazirCP . Patient‐reported outcomes: a new era in clinical research. Perspectives in Clinical Research2011;2(4):137‐44. ">Deshpande 2011</a>). Efforts are being made to develop more reliable tools. A recent study developed and validated a reliable arthralgia severity measurement instrument, the Patient‐Reported Arthralgia Inventory (PRAI), in postmenopausal breast cancer patients with AIMSS (<a href="./references#CD012988-bbs2-0051" title="CastelLD , WallstonKA , SavilleBR , AlvarezJR , ShieldsBD , FeurerID , et al. Validity and reliability of the patient‐reported arthralgia inventory: validation of a newly‐developed survey instrument to measure arthralgia. Patient Related Outcome Measures2015;6:205‐14. ">Castel 2015</a>). Other newly developed tools including electronic/web‐based patient‐reported outcomes may also improve research capability. Better standardisation may improve the quality of the evidence generated, and allow for relevant outcomes to be compared in future meta‐analysis. Patient‐reported outcome monitoring may potentially improve care delivery and patient outcomes (<a href="./references#CD012988-bbs2-0097" title="NippR , TemelJ . The patient knows best: incorporating patient‐reported outcomes into routine clinical care. Journal of the National Cancer Institute2017;109(9):djx044. ">Nipp 2017</a>), and incorporation of these newer tools should be a priority for further research. It is also important for future AIMSS trials to incorporate quality‐of‐life patient‐reported outcomes in their outcome assessments, as we become increasingly aware of the impact of AIMSS on aspects of quality of life other than pain. The optimal timing of outcome measures remains to be established, as AIMSS fluctuates with time (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>). Future trials should endeavour to include longer‐term follow‐up assessments to establish if any positive effects of exercise continue beyond the intervention period. </p> <p>The next phase of ongoing research may examine comparison between different types, frequencies and intensities of exercise in AIMSS. Goal setting, setting of graded tasks and behavioural instructions are the common features of exercise interventions in people with cancer that meet the recommendation targets with high adherence rates (<a href="./references#CD012988-bbs2-0113" title="TurnerRR , SteedL , QuirkH , GreasleyRU , SaxtonJM , TaylorSJ , et al. Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database of Systematic Reviews2018, Issue 9. [DOI: 10.1002/14651858.CD010192.pub3] ">Turner 2018</a>). These differences between the studies in AIMSS are yet to be examined. Similarly, patient preference between different exercise interventions trialled in AIMSS also remains unknown, and this should be examined. If the benefit of exercise was firmly established in other AIMSS outcomes, such research questions may be of greater merit. However, this research would need to be conducted in the complex environment of current recommended exercise guidelines for women with breast cancer that reports low compliance rates, and be appropriate for different populations and healthcare settings. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012988-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012988-sec-0029"></div> <div class="table" id="CD012988-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS)<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> exercise therapies<br/> <b>Comparison:</b> standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI) with the use of exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in worst pain scores</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.23 SD lower<br/> (0.78 lower to 0.32 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>284<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in worst pain scores. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in stiffness scores</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The effect in this single study ranged from MD 0.76 points lower (1.67 lower to 0.15 higher) to MD 0.42 points lower (2.10 lower to 1.26 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that exercise therapies result in little to no difference in overall change in stiffness scores. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in grip strength</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 points higher<br/> (0.55 lower to 1.15 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>6,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in grip strength. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in health‐related quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We could not calculate total score. Effect within subscales of HR‐QoL ranged from MD 1.88 points higher (2.69 lower to 6.45 higher) to 9.70 points higher (1.67 higher to 17.73 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in health‐related quality of life. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in cancer‐specific quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.58 points higher<br/> (0.61 lower to 9.78 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,11,12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in disease‐specific quality of life. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects secondary to the intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Nil adverse events in either arm.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>331<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that exercise therapies are low risk, with no adverse events reported across four studies </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adherence to aromatase inhibitors</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 2.43<br/> (0.41 to 14.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>224<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>3,13,14</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on adherence to aromatase inhibitors. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>AIMSS:</b> aromatase inhibitor‐induced musculoskeletal symptoms; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation; <b>SMD:</b> standardised mean difference; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias concerns with each study, including lack of blinding of participants/personnel and outcome assessors. There were serious concerns regarding random sequence allocation and allocation concealment in one study. High risk of attrition bias in three studies. Concerns regarding exercise contamination in the control arm in two studies. Downgraded 1 point.<br/> <sup>2</sup>Significant statistical heterogeneity, I<sup>2</sup> = 79%, resulting in downgrading 1 point for inconsistency.<br/> <sup>3</sup>Multiple studies only written in abstract form, without pursuing full publication, including studies that had unpublished results relevant to this outcome. Strong suspicion of publication bias, and therefore downgraded 1 point.<br/> <sup>4</sup>Downgraded 1 point for imprecision, due to a number of factors: sample sizes were too small to determine an accurate result; the width of the confidence interval is consistent with both benefit and harm; and one of the studies included skewed data.<br/> <sup>5</sup>High risk of bias for this study, due to serious concerns with random sequence generation and allocation concealment, and also the lack of blinding of participants/personnel and outcome assessors. In addition, high risk of attrition bias. Selective reporting bias for one study for this outcome, which did not report results. Downgraded 1 point.<br/> <sup>6</sup>Small number of participants and null effect and appreciable harm and benefit included in the confidence interval. Downgraded 1 point.<br/> <sup>7</sup>Two studies did not report grip‐strength results, as only published in abstract form. Downgraded 1 point for publication bias.<br/> <sup>8</sup>Downgraded 1 point for risk of bias, due to inability to blind participants/personnel to the intervention, and lack of blinding for outcome assessors. Concerns regarding incomplete outcome data and exercise contamination in the control arm.<br/> <sup>9</sup>Imprecision was present, due to wide range of confidence intervals, a sample size that was too small to provide accurate results, and inclusion of one study that had skewed data. Downgraded 1 point.<br/> <sup>10</sup>Downgraded 1 point for risk of bias. Lack of blinding for participants/personnel, and inadequate allocation concealment. Judged as high risk of attrition bias in one study, and concerns regarding exercise contamination in the control arms of both studies. Poor adherence to exercise in one study.<br/> <sup>11</sup>Downgraded 1 point for imprecision, due to small sample size and wide confidence intervals, which included both the null effect and appreciable benefit.<br/> <sup>12</sup>Risk of bias concerns with each study, including lack of blinding of participants/personnel and outcome assessors. There were serious concerns regarding random sequence allocation and allocation concealment in one study. High risk of attrition bias in both studies. In addition, concerns regarding exercise contamination in the control arm in one study. Downgraded 1 point.<br/> <sup>13</sup>Downgraded 1 point for imprecision, because the sample size was small, and the event rate low.<br/> <sup>14</sup>Downgraded 1 point due to high risk of bias with each study, including high risk of attrition bias in both studies, and one study only being published in abstract form so limited data available. It is unclear how much lack of blinding of participants and personnel may have impacted on this outcome. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012988-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012988-sec-0030"></div> <section id="CD012988-sec-0031"> <h3 class="title" id="CD012988-sec-0031">Description of the condition</h3> <p>Breast cancer remains a major public health problem despite advances in screening and treatment. There was an estimated 1.67 million new cases diagnosed in 2012, making breast cancer the most common non‐skin cancer in women (<a href="./references#CD012988-bbs2-0063" title="FerlayJ , SoerjomataramI , ErvikM , DikshitR , EserS , MathersC , et al. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. globocan.iarc.fr. Lyon, France: International Agency for Research on Cancer, (accessed prior to 14 March 2018). [http://globocan.iarc.fr,] ">Ferlay 2012</a>). With 522,000 deaths, breast cancer was the fifth most common cause of cancer death globally in 2012 (<a href="./references#CD012988-bbs2-0063" title="FerlayJ , SoerjomataramI , ErvikM , DikshitR , EserS , MathersC , et al. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. globocan.iarc.fr. Lyon, France: International Agency for Research on Cancer, (accessed prior to 14 March 2018). [http://globocan.iarc.fr,] ">Ferlay 2012</a>). In women in high‐income countries, breast cancer is second to lung cancer as the leading cause of cancer death, and in low‐ to middle‐income countries, breast cancer remains the leading cause of cancer death (<a href="./references#CD012988-bbs2-0063" title="FerlayJ , SoerjomataramI , ErvikM , DikshitR , EserS , MathersC , et al. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. globocan.iarc.fr. Lyon, France: International Agency for Research on Cancer, (accessed prior to 14 March 2018). [http://globocan.iarc.fr,] ">Ferlay 2012</a>). Hormone receptor‐positive breast cancer, that is, oestrogen receptor (ER)‐positive, or progesterone receptor (PR)‐positive, or both, accounts for about 80% of breast cancer, with women with early breast cancer usually having oestrogen or 'endocrine‐sensitive' cancer (<a href="./references#CD012988-bbs2-0095" title="NadjiM , Gomez‐FernandezC , Ganjei‐AzarP , MoralesAR . Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. American Journal of Clinical Pathology2005;123(1):21‐7. ">Nadji 2005</a>). Treatment of postmenopausal women with hormone receptor‐positive breast cancer with aromatase inhibitor (AI) medications is effective. Five years of AI therapy in early breast cancer improves disease‐free survival (DFS) and breast cancer specific survival (BCSS) when compared to another hormonal therapy, tamoxifen (<a href="./references#CD012988-bbs2-0043" title="AydinerA . Meta‐analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women. Breast2013;22(2):121‐9. ">Aydiner 2013</a>; <a href="./references#CD012988-bbs2-0059" title="Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient‐level meta‐analysis of the randomised trials. Lancet2015;386(10001):1341‐52. ">EBCTCG 2015</a>)<i>.</i> Recent guidelines (<a href="./references#CD012988-bbs2-0048" title="BursteinHJ , LacchettiC , AndersonH , BuchholzTA , DavidsonNE , GelmonKA , et al. Adjuvant endocrine therapy for women with hormone receptor‐positive breast cancer: ASCO Clinical Practice Guideline Focused Update. Journal of Clinical Oncology2019;37(5):423‐38. ">Burstein 2019</a>) now recommend consideration of 10 years of AI treatment for certain high‐risk subgroups, such as node‐positive patients. </p> <p>However, AIs are commonly associated with joint and muscular symptoms, referred to as aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS; <a href="./references#CD012988-bbs2-0089" title="LintermansA , LaenenA , VanCalsterB , VanHoydonckM , PansS , VerhaegheJ , et al. Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor‐induced musculoskeletal syndrome: 2‐year follow‐up data. Annals of Oncology2013;24(2):350‐5. ">Lintermans 2013</a>). Nearly half of all women on AIs experience these side effects (<a href="./references#CD012988-bbs2-0045" title="BeckweeD , LeysenL , MeuwisK , AdriaenssensN . Prevalence of aromatase inhibitor‐induced arthralgia in breast cancer: a systematic review and meta‐analysis. Supportive Care in Cancer2017;25(5):1673‐86. ">Beckwee 2017</a>). AIMSS often presents as symmetrical pain or soreness in multiple joints, and is also often associated with early morning stiffness (<a href="./references#CD012988-bbs2-0047" title="BursteinHJ . Aromatase inhibitor‐associated arthralgia syndrome. Breast2007;16(3):223‐34. ">Burstein 2007</a>). Despite the survival advantage of AIs, these side effects are causing a quarter to half of all women on this treatment to discontinue (<a href="./references#CD012988-bbs2-0052" title="ChimK , XieSX , StrickerCT , LiQS , GrossR , FarrarJT , et al. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors. BMC Cancer2013;13:401. ">Chim 2013</a>; <a href="./references#CD012988-bbs2-0074" title="HenryNL , AzzouzF , DestaZ , LiL , NguyenAT , LemlerS , et al. Predictors of aromatase inhibitor discontinuation as a result of treatment‐emergent symptoms in early‐stage breast cancer. Journal of Clinical Oncology2012;30(9):936‐42. ">Henry 2012</a>; <a href="./references#CD012988-bbs2-0084" title="KadakiaKC , SnyderCF , KidwellKM , SeewaldNJ , FlockhartDA , SkaarTC , et al. Patient‐reported outcomes and early discontinuation in aromatase inhibitor‐treated postmenopausal women with early stage breast cancer. Oncologist2016;21(5):539‐46. ">Kadakia 2016</a>). An association between switching AIs and the development of new musculoskeletal pain has been identified (<a href="./references#CD012988-bbs2-0085" title="Kemp‐CaseyA , RougheadEE , SaundersC , BoyleF , BulsaraM , PreenDB . Switching between endocrine therapies for primary breast cancer: frequency and timing in Australian clinical practice. Asia‐Pacific Journal of Clinical Oncology2017;13(2):e161‐70. ">Kemp‐Casey 2017</a>). If AIMSS can be managed, then quality of life and adherence to treatment may improve, and the survival advantage from using AI therapy may not be compromised. </p> </section> <section id="CD012988-sec-0032"> <h3 class="title" id="CD012988-sec-0032">Description of the intervention</h3> <p>Exercise can be defined as "a subset of physical activity that is planned, structured, repetitive, and has as a final or an intermediate objective of the improvement or maintenance of physical fitness" (<a href="./references#CD012988-bbs2-0050" title="CaspersenCJ , PowellKE , ChristensonGM . Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research. Public Health Reports1985;100(2):126‐31. ">Caspersen 1985</a>)<i>.</i> The definition of therapy in the <a href="./references#CD012988-bbs2-0092" title="Merriam‐WebsterDictionary . Definition of therapy. www.merriam‐webster.com (accessed 8 March 2018). [www.merriam‐webster.com/] ">Merriam‐Webster</a> dictionary is the "therapeutic treatment especially of bodily, mental, or behavioral disorder" (<a href="./references#CD012988-bbs2-0092" title="Merriam‐WebsterDictionary . Definition of therapy. www.merriam‐webster.com (accessed 8 March 2018). [www.merriam‐webster.com/] ">Merriam‐Webster</a>). Exercise therapies investigated in this review involve a variety of therapeutic interventions intended to improve or maintain fitness. These include, but are not restricted to, cardiovascular and resistance exercises, yoga, tai‐chi, aquatic exercise, walking and pilates. </p> </section> <section id="CD012988-sec-0033"> <h3 class="title" id="CD012988-sec-0033">How the intervention might work</h3> <p>The cause of AIMSS is unknown, and therefore the mechanism for the effectiveness of exercise therapies on AIMSS cannot be ascertained. There has been a growing interest in conducting research into the effect of exercise on a wide variety of conditions, such as the effect on cancer mortality, recurrence and treatment‐related adverse effects (<a href="./references#CD012988-bbs2-0053" title="CormieP , ZopfEM , ZhangX , SchmitzKH . The impact of exercise on cancer mortality, recurrence, and treatment‐related adverse effects. Epidemiologic Reviews2017;39(1):71‐92. ">Cormie 2017</a>), cancer‐related fatigue and mobility (<a href="./references#CD012988-bbs2-0057" title="DennettAM , PeirisCL , ShieldsN , PrendergastLA , TaylorNF . Moderate‐intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta‐regression. Journal of Physiotherapy2016;62(2):68‐82. ">Dennett 2016</a>), quality of life in cancer survivors (<a href="./references#CD012988-bbs2-0093" title="MishraSI , SchererRW , GeiglePM , BerlansteinDR , TopalogluO , GotayCC , et al. Exercise interventions on health‐related quality of life for cancer survivors. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD007566.pub2] ">Mishra 2012</a>), the immune system (<a href="./references#CD012988-bbs2-0111" title="SzlezakAM , SzlezakSL , KeaneJ , TajouriL , MinahanC . Establishing a dose‐response relationship between acute resistance‐exercise and the immune system: protocol for a systematic review. Immunology Letters2016;180:54‐65. ">Szlezak 2016</a>), and rheumatological conditions, such as osteoarthritis (<a href="./references#CD012988-bbs2-0067" title="FransenM , McConnellS , Hernandez‐MolinaG , ReichenbachS . Exercise for osteoarthritis of the hip. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD007912.pub2] ">Fransen 2014</a>; <a href="./references#CD012988-bbs2-0099" title="OsterasN , KjekenI , SmedslundG , MoeRH , Slatkowsky‐ChristensenB , UhligT , et al. Exercise for hand osteoarthritis. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010388.pub2] ">Osteras 2017</a>). There has been a large phase III randomised controlled trial (RCT) investigating the intervention of cardiovascular and resistance exercise in the treatment of AIMSS, which reported a clinically significant benefit with the use of exercise (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>). Therefore, even though the mechanism of any potential benefit of exercise in this area is largely unknown, a positive result from a large phase III RCT, plus multiple other smaller studies in this field, warrants a comprehensive review of these therapies. </p> </section> <section id="CD012988-sec-0034"> <h3 class="title" id="CD012988-sec-0034">Why it is important to do this review</h3> <p>AIMSS has a clinical impact on the management of women with breast cancer, as studies have shown substantial rates of suboptimal adherence to AIs (<a href="./references#CD012988-bbs2-0046" title="BrierMJ , ChamblessDL , GrossR , ChenJ , MaoJJ . Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors. Cancer2017;123(1):169‐76. ">Brier 2017</a>; <a href="./references#CD012988-bbs2-0071" title="HadjiP , JackischC , BoltenW , BlettnerM , HindenburgHJ , KleinP , et al. COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy. Annals of Oncology2014;25(2):372‐7. ">Hadji 2014</a>; <a href="./references#CD012988-bbs2-0074" title="HenryNL , AzzouzF , DestaZ , LiL , NguyenAT , LemlerS , et al. Predictors of aromatase inhibitor discontinuation as a result of treatment‐emergent symptoms in early‐stage breast cancer. Journal of Clinical Oncology2012;30(9):936‐42. ">Henry 2012</a>; <a href="./references#CD012988-bbs2-0075" title="HershmanDL , ShaoT , KushiLH , BuonoD , TsaiWY , FehrenbacherL , et al. Early discontinuation and non‐adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment2011;126(2):529‐37. ">Hershman 2011</a>; <a href="./references#CD012988-bbs2-0100" title="PartridgeAH , LaFountainA , MayerE , TaylorBS , WinerE , Asnis‐AlibozekA . Adherence to initial adjuvant anastrozole therapy among women with early‐stage breast cancer. Journal of Clinical Oncology2008;26(4):556‐62. ">Partridge 2008</a>; <a href="./references#CD012988-bbs2-0103" title="PresantCA , BossermanL , YoungT , VakilM , HornsR , UpadhyayaG , et al. Aromatase inhibitor‐associated arthralgia and/or bone pain: frequency and characterization in non‐clinical trial patients. Clinical Breast Cancer2007;7(10):775‐8. ">Presant 2007</a>). Non‐compliance with endocrine therapies in the adjuvant setting may impact on women's survival (<a href="./references#CD012988-bbs2-0075" title="HershmanDL , ShaoT , KushiLH , BuonoD , TsaiWY , FehrenbacherL , et al. Early discontinuation and non‐adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment2011;126(2):529‐37. ">Hershman 2011</a>). To date, there is limited evidence regarding the best management options for AIMSS. With a growing emphasis on the management of survivorship issues for women with early breast cancer, this area of research is very topical, and of increasing importance. It has been identified that oncologists may feel ill‐equipped to prescribe exercise to women with early breast cancer (<a href="./references#CD012988-bbs2-0110" title="SmaradottirA , SmithAL , BorgertAJ , OettelKR . Are we on the same page? Patient and provider perceptions about exercise in cancer care: a focus group study. Journal of the National Comprehensive Cancer Network2017;15(5):588‐94. ">Smaradottir 2017</a>), and providing a stronger evidence base for the role of exercise in managing symptoms may assist with this issue. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012988-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012988-sec-0035"></div> <p>To assess the effects of exercise therapies on the prevention or management of aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS) in women with stage I to III hormone receptor‐positive breast cancer. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012988-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012988-sec-0036"></div> <section id="CD012988-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012988-sec-0038"> <h4 class="title">Types of studies</h4> <p>All RCTs looking at the prevention or management of AIMSS in women with stage I to III hormone receptor‐positive breast cancer. AIMSS was defined by the study authors of each trial. We excluded animal and in vitro studies. We considered studies in all languages for inclusion. </p> </section> <section id="CD012988-sec-0039"> <h4 class="title">Types of participants</h4> <p>Women aged 18 years and older with stage I to III ER‐positive, or PR‐positive breast cancer, or both, who were being treated adjuvantly with AIs. </p> </section> <section id="CD012988-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included all exercise therapy interventions, such as aerobic and resistance exercise, tai chi, yoga and aqua aerobics. We excluded musculoskeletal manipulation therapies, such as massage and kinesiology. We did not impose any restriction on the type of comparator arm; comparator arms could include an alternative type of exercise, no exercise, or a waiting list control. </p> </section> <section id="CD012988-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012988-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012988-list-0001"> <li> <p>Prevention and treatment of symptoms of AIMSS (pain, stiffness, and grip strength) from baseline. These were preferably assessed by validated questionnaires, such as the Visual Analogue Scale (VAS), Brief Pain Inventory (BPI), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Functional Assessment of Cancer Therapy – General (FACT‐G), Medical Outcome Study Short Form 36 (SF‐36), and the Modified Score for the Assessment of Chronic Rheumatoid Affections of the Hands (M‐SACRAH) </p> </li> <li> <p>Safety of the intervention, including adverse effects, such as injury</p> </li> </ul> </p> </section> <section id="CD012988-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012988-list-0002"> <li> <p>Incidence of AIMSS</p> </li> <li> <p>Persistence and compliance of women continuing to take their AI medication due to the intervention </p> </li> <li> <p>Participant health‐related quality of life, which was also preferably assessed by validated patient/participant‐reported outcome questionnaires </p> </li> <li> <p>Participant cancer‐specific quality of life</p> </li> <li> <p>Breast cancer‐specific survival</p> </li> <li> <p>Overall survival</p> </li> </ul> </p> </section> </section> </section> <section id="CD012988-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012988-sec-0045"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist (KR) designed and conducted systematic searches in the selected databases and trial registries without language, publication year or publication status restrictions. Cochrane Breast Cancer's Information Specialist conducted the search of the group's Specialised Register. Where appropriate, the search strategies also included adaptations of the highly sensitive search strategy designed by the Cochrane Collaboration (<a href="./references#CD012988-bbs2-0088" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from www.handbook.cochrane.org. ">Lefebvre 2011</a>), and the search filter for CINAHL (EBSCO) created by Mark Clowes at <a href="./references#CD012988-bbs2-0109" title="Scottish Intercollegiate Guidelines Network (SIGN). Search filters. www.sign.ac.uk/methodology/filters.html#random2011. ">SIGN</a> for identifying RCTs and controlled clinical trials. </p> <p>We searched the following databases and trials registries.</p> <p> <ul id="CD012988-list-0003"> <li> <p>Cochrane Breast Cancer's Specialised Register. We extracted and considered for inclusion in the review trials with the key words "breast cancer" and related terms, "aromatase inhibitors", "exemestane", "anastrozole", "letrozole", "exercise", "physical activity", "resistance training", "yoga", "walking", "T'ai chi"; searched on 16 April 2018. </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 11) in the Cochrane Library (searched 13 December 2018). See <a href="./appendices#CD012988-sec-0115">Appendix 1</a> </p> </li> <li> <p>MEDLINE (via PubMed) from 1946 to December 2018 (searched 13 December 2018). See <a href="./appendices#CD012988-sec-0116">Appendix 2</a> </p> </li> <li> <p>Embase (via Embase.com) from 1947 to December 2018 (searched 13 December 2018). See <a href="./appendices#CD012988-sec-0117">Appendix 3</a> </p> </li> <li> <p>CINAHL (via EBSCO) from 1937 to present. (Last search 13 December 2018). See <a href="./appendices#CD012988-sec-0118">Appendix 4</a> </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) search portal (<a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">apps.who.int/trialsearch</a>) for all prospectively registered and ongoing trials (searched on 18 August 2019). See <a href="./appendices#CD012988-sec-0119">Appendix 5</a> </p> </li> <li> <p>Clinicaltrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov;</a> searched on 18 August 2019). See <a href="./appendices#CD012988-sec-0120">Appendix 6</a> </p> </li> </ul> </p> </section> <section id="CD012988-sec-0046"> <h4 class="title">Searching other resources</h4> <section id="CD012988-sec-0047"> <h5 class="title">Bibliographic searching</h5> <p>We searched reference and citation lists of identified relevant trials and reviews to try and identify further studies. We attempted to obtain a copy of the full article for each reference reporting a potentially eligible trial. Where this was not possible, such as with the inclusion of conference abstracts, we sourced additional information from clinical trials databases, and we attempted to contact study authors to provide additional information. </p> </section> <section id="CD012988-sec-0048"> <h5 class="title">Grey searching</h5> <p>We screened conference abstracts from major conferences such as the San Antonio Breast Cancer Symposium (SABCS) and American Society of Clinical Oncology (ASCO) up to December 2018 and any additional papers identified during the attendance at the 2019 San Antonio Breast Cancer Symposium (NW) were reported and added for inclusion, where relevant. </p> </section> </section> </section> <section id="CD012988-sec-0049"> <h3 class="title" id="CD012988-sec-0049">Data collection and analysis</h3> <section id="CD012988-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Review authors (SF, NW, KER and KR) screened retrieved abstracts from the literature search and assessed whether the abstracts met the specified selection criteria. Subsequently, we reviewed the full texts of all remaining studies to ensure that they still met the selection criteria. At least two review authors reviewed each study to ensure that they met the selection criteria. We resolved any disagreements on study selection by involving a separate review author (NW or KER). We recorded the selection process in a PRISMA flow diagram (<a href="#CD012988-fig-0001">Figure 1</a>; <a href="./references#CD012988-bbs2-0094" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group (2009). Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA Statement. PLoS Medicine 6;7:e1000097. [DOI: 10.1371/journal.pmed1000097] ">Moher 2009</a>). We documented the reason for excluding any studies in the <a href="./references#CD012988-sec-0129" title="">Characteristics of excluded studies</a> tables. There were no studies reported in languages other than English identified during this search, and therefore no translation was required. </p> <div class="figure" id="CD012988-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD012988-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD012988-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>We performed data extraction using a standard data extraction form that included the following: </p> <section id="CD012988-sec-0052"> <h5 class="title">Characteristics of the study</h5> <p> <ul id="CD012988-list-0004"> <li> <p>Study sponsors and author affiliations</p> </li> <li> <p>Study funding</p> </li> <li> <p>Methods, including study design, method of sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcomes, participant attrition and exclusions, and selective outcome reporting </p> </li> <li> <p>Full‐text availability versus abstract only</p> </li> </ul> </p> </section> <section id="CD012988-sec-0053"> <h5 class="title">Characteristics of the study population</h5> <p> <ul id="CD012988-list-0005"> <li> <p>Country of enrolment</p> </li> <li> <p>Inclusion/exclusion criteria</p> </li> <li> <p>Study definition of AIMSS</p> </li> <li> <p>Number of participants in each treatment arm</p> </li> <li> <p>Mean and range of participant ages</p> </li> <li> <p>Type of AI prescribed to the participant</p> </li> </ul> </p> </section> <section id="CD012988-sec-0054"> <h5 class="title">Characteristics of the intervention</h5> <p> <ul id="CD012988-list-0006"> <li> <p>Description of the intervention</p> <ul id="CD012988-list-0007"> <li> <p>Aerobic/resistance/combination/other</p> </li> <li> <p>Exercise intensity: mild/moderate/vigorous</p> </li> <li> <p>Frequency and duration of sessions</p> </li> <li> <p>Duration of intervention period</p> </li> <li> <p>Supervised versus home‐based; group versus individual</p> </li> </ul> </li> <li> <p>Details of control or waiting list group</p> </li> <li> <p>Compliance with intervention</p> </li> <li> <p>Safety</p> </li> </ul> </p> </section> <section id="CD012988-sec-0055"> <h5 class="title">Characteristics of the outcomes</h5> <p> <ul id="CD012988-list-0008"> <li> <p>Scoring systems used (and documentation of participant‐reported outcomes versus investigator‐reported outcomes) </p> </li> <li> <p>Outcomes of pain, stiffness, grip strength and health‐related quality of life</p> </li> <li> <p>Change in incidence of AIMSS</p> </li> <li> <p>Timing of outcome data collection, including length of time between intervention and last collected outcome measurement </p> </li> <li> <p>Follow‐up period</p> </li> </ul> </p> <p>Two review authors (KER and SF) performed data extraction and a third review author (NW) resolved any disagreements. KER and SF entered data into Review Manager 5 (<a href="./references#CD012988-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). Where there was more than one publication for a study, we extracted the data from all publications as required, but we considered the most recent version of the study to be the primary reference. We combined records relating to the same study under an overall study name or ID. </p> </section> </section> <section id="CD012988-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We performed assessment of risk of bias for all RCTs using Cochrane's 'Risk of bias' assessment tool (<a href="./references#CD012988-bbs2-0080" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). This included the assessment of seven specific domains: random sequence generation; allocation concealment; blinding of participants and personnel; blinding of outcome assessment; incomplete outcome data; selective reporting; and other sources of bias. We assessed each study domain as high risk, low risk or unclear risk. Two review authors (KER, SF, NW or KR) independently assessed each study for risk of bias and a third review author (KER or NW) resolved any disagreements. Where there was incomplete reporting of the conduct of a study, we attempted to contact the authors of the study to clarify any uncertainties. 'Risk of bias' tables for each study are presented in the <a href="./references#CD012988-sec-0128" title="">Characteristics of included studies</a> table and a summary table, listing the 'Risk of bias' judgement for all studies is presented <a href="#CD012988-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD012988-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD012988-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> </section> <section id="CD012988-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <p>We expected that studies would use a variety of different tools to measure the outcomes of interest (pain, stiffness, grip strength and health‐related quality of life) and would mainly be reporting continuous outcomes. Therefore, we calculated the treatment effect by undertaking a standardised mean difference (SMD) analysis (SMD = difference in mean outcomes/standard deviation of outcomes among participants; <a href="./references#CD012988-bbs2-0056" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), to combine data from different instruments measuring the same domain. When studies used the same participant‐reported outcome tool for a single outcome, we combined the data for meta‐analysis using mean difference (MD). If there was minimal heterogeneity between studies, we used a fixed‐effect model. This is different from our protocol, as we originally had proposed to use only the random‐effects model, due to expected heterogeneity amongst the varying interventions and assessment tools. In our revised method, we still used a random‐effects model, but have also reported the results of the fixed‐effect model. Due to the small number of studies, and small number of participants in some studies, we also performed a random‐effects meta‐analysis using the Hartung, Knapp, Sidik and Jonkman (HKSJ) approach (<a href="./references#CD012988-bbs2-0082" title="IntHoutJ , IoannidisJ P , BormGF . The Hartung‐Knapp‐Sidik‐Jonkman method for random effects meta‐analysis is straightforward and considerably outperforms the standard DerSimonian‐Laird method. BMC Medical Research Methodology2014;14:25. ">IntHout 2014</a>). </p> <p>For studies which we could not obtain standard deviations (SD), we imputed the SD as per <a href="./references#CD012988-bbs2-0078" title="HigginsJP , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from www.handbook.cochrane.org.. ">Higgins 2011a</a>. Where the SD was not available in the published study, or from study authors, we used the following formula to determine the SD: SD = √n × (upper limit 95% CI – lower limit 95% CI)/(2 x T value calculated by the T distribution), where n is the sample size and CI is the confidence interval. We estimated appropriate T values for smaller sample sizes using the TINV function (TINV(1‐0.95,n‐1)) in <a href="./references#CD012988-bbs2-0062" title="Microsoft. Excel. Microsoft, 2016. ">Excel</a>. We could then use the calculated SD to calculate the SMD. These calculations were guided by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012988-bbs2-0079" title="HigginsJP , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from www.handbook.cochrane.org.. ">Higgins 2011b</a>), and results were confirmed with the calculator available on Review Manager 5 (<a href="./references#CD012988-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>We calculated the published confidence intervals in the HOPE study (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), on the difference in the means for each group, so we calculated a SD for the change in means, rather than the final value for each arm of the study. By using these calculations, our review ran the risk of giving greater weight to the studies that reported change‐from‐baseline SD, as the SD in these studies may have been more precise than studies only reporting final value SD, due to the smaller SD (<a href="./references#CD012988-bbs2-0056" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). Therefore, where possible, we performed a separate analysis on final values and change‐from‐baseline values, and compared the results. Where we used a combination of final value confidence intervals and change‐from‐baseline values in a meta‐analysis, we highlighted it in the text for the result. </p> <p><a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a> reported interquartile range (IQR) and median values, rather than mean and standard deviations. This is often an indicator that the data are skewed, so should be incorporated into a meta‐analysis with caution (<a href="./references#CD012988-bbs2-0078" title="HigginsJP , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from www.handbook.cochrane.org.. ">Higgins 2011a</a>). To calculate SD from IQR, we used the following formula: SD = (q3 ‐ q1)/1.35, where q3 is quartile 3 and q1 is quartile 1 (<a href="./references#CD012988-bbs2-0079" title="HigginsJP , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from www.handbook.cochrane.org.. ">Higgins 2011b</a>). </p> <p>For dichotomous outcomes, we measured the treatment outcome by the odds ratio (OR), in combination with a 95% confidence interval (CI). </p> </section> <section id="CD012988-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>There were no studies that may have created unit of analysis issues, such as cross‐over trials or trials with multiple treatment arms. </p> </section> <section id="CD012988-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>In the case of missing data, wherever possible, we sourced additional information through clinical trials registries or data repositories. Where the required data were still not available, we contacted original corresponding authors via email and gave them three weeks to reply to the request. If the corresponding authors did not reply, we attempted further contact with the original investigators, and either the first or last author of each paper (if not the primary corresponding author). Where we were unable to obtain missing data, we have included an explanation for this in the <a href="#CD012988-sec-0103">Discussion</a> section of our review. </p> </section> <section id="CD012988-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the percentage of total variation across studies that is due to heterogeneity rather than chance using I<sup>2</sup> statistic (<a href="./references#CD012988-bbs2-0077" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). We also used the Chi<sup>2</sup> test and visual inspection of forest plots, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012988-bbs2-0056" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). Based on this, an I<sup>2</sup> statistic value of: </p> <p> <ul id="CD012988-list-0009"> <li> <p>30% to 60% may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity; and</p> </li> <li> <p>75% to 100% represents considerable heterogeneity (<a href="./references#CD012988-bbs2-0056" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> </li> </ul> </p> <p>The importance of the I<sup>2</sup> statistic result depends on the magnitude and direction of effects, and the strength of evidence for heterogeneity. Based on <a href="./references#CD012988-bbs2-0056" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>, a Chi<sup>2</sup> test greater than the degrees of freedom (df) and a small P value (e.g. P &lt; 0.05) indicates significant heterogeneity, and we applied this guideline in the current analysis. </p> </section> <section id="CD012988-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We included one funnel plot in the assessment of reporting biases for the outcome with the largest number of studies. We could not undertake any further assessments due to the small number of studies contributing data to each outcome. </p> </section> <section id="CD012988-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analysis using Review Manager 5 software (<a href="./references#CD012988-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). Where there was only low statistical heterogeneity, we performed a fixed‐effect meta‐analysis. Where there was at least moderate statistical heterogeneity present, we used a random‐effects meta‐analysis, using the inverse variance method to combine the data. </p> <p>We reported the meta‐analysis mainly by forest plots and the 'Summary of findings' table (see <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>). For outcomes where there was an insufficient number of studies for us to pool for meta‐analysis (i.e. fewer than two studies), or we could not combine the data, we presented our findings in a narrative manner. </p> <section id="CD012988-sec-0063"> <h5 class="title">Summary of findings and assessment of the certainty of the evidence</h5> <p>We developed a 'Summary of findings' table to assess the certainty of evidence using the GRADE approach, as detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, Chapter 11 (<a href="./references#CD012988-bbs2-0108" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>). The GRADE approach assesses the evidence using five considerations: study limitations, consistency of effect, imprecision, indirectness and publication bias. The key outcomes we included in the <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a> were: </p> <p> <ul id="CD012988-list-0010"> <li> <p>overall change in worst pain scores;</p> </li> <li> <p>overall change in stiffness scores;</p> </li> <li> <p>overall change in grip strength;</p> </li> <li> <p>overall change in health‐related quality‐of‐life scores;</p> </li> <li> <p>overall change in cancer‐specific quality of life;</p> </li> <li> <p>adverse effects, secondary to the intervention; and</p> </li> <li> <p>persistence and compliance of participants continuing to take their AI medication due to the intervention. </p> </li> </ul> </p> <p>The 'Summary of findings' table in our review was different to the 'Summary of findings' table that we proposed in our protocol. We had initially intended to assess the overall change in the incidence of AIMSS. There were no studies that addressed the incidence of AIMSS as a result of exercise, and therefore we substituted the overall change in the incidence of AIMSS for one of our secondary outcomes, the overall change in health‐related quality of life. Quality of life was further defined by incorporating both 'health‐related quality of life' and 'cancer‐specific quality of life'. We developed the 'Summary of findings' table using <a href="./references#CD012988-bbs2-0070" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed October 2017. Hamilton (ON): GRADE Working Group, McMaster University. ">GRADEpro GDT</a> software (<a href="./references#CD012988-bbs2-0070" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed October 2017. Hamilton (ON): GRADE Working Group, McMaster University. ">GRADEpro GDT</a>). Two review authors (KER, NW) independently assessed the evidence using the GRADE approach and a third review author (KR) resolved any disputes. </p> </section> </section> <section id="CD012988-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not undertake any subgroup analyses, as there were insufficient studies and participants to undertake any meaningful subgroup analysis within this review. </p> </section> <section id="CD012988-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>There were not enough studies to in our review to undertake meaningful sensitivity analyses. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012988-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012988-sec-0066"></div> <section id="CD012988-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD012988-sec-0068"> <h4 class="title">Results of the search</h4> <p>The searches of the identified databases retrieved 1187 results. Our searches of other resources, such as bibliography and citation searching, and searching of the grey literature identified 19 additional records that appeared to meet the inclusion criteria. Once duplicates had been removed, there were 910 records for title and abstract screening, where we excluded 860 records. Where possible, we obtained the full text of the remaining 50 papers or register records. We excluded 32 articles (see <a href="./references#CD012988-sec-0129" title="">Characteristics of excluded studies</a>). We included seven studies (relating to 14 references) and identified four ongoing studies relevant to our inclusion criteria (see <a href="./references#CD012988-sec-0130" title="">Characteristics of ongoing studies</a>). The process is detailed further in the study flow diagram (see <a href="#CD012988-fig-0001">Figure 1</a>; <a href="./references#CD012988-bbs2-0094" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group (2009). Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA Statement. PLoS Medicine 6;7:e1000097. [DOI: 10.1371/journal.pmed1000097] ">Moher 2009</a>). </p> </section> <section id="CD012988-sec-0069"> <h4 class="title">Included studies</h4> <p>The final selection of studies, based on review author consensus, resulted in seven studies for inclusion. Study characteristics and outcomes can be viewed in the <a href="./references#CD012988-sec-0128" title="">Characteristics of included studies</a> table. Three of these studies had been published as full texts (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), and four studies (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>), were published in abstract or poster form only. We were able to retrieve additional data from the <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a> trial via study author correspondence. </p> <p>Three studies enrolled participants in the USA (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>), one in the UK (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>), one in Canada (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>), one in Japan (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>) and one in Australia (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). All studies were RCTs, but four of these studies were designed as feasibility studies (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). The majority of the studies were investigating the treatment of AIMSS, with only one study investigating the prevention of AIMSS, which enrolled participants at the time of AI initiation (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). </p> <section id="CD012988-sec-0070"> <h5 class="title">Population</h5> <p>There were 400 participants enrolled across the seven studies. The sample sizes of the included studies ranged from 22 to 108. Four studies reported participant mean ages (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), and ranged from 61 to 63.8 years. Two studies gave age ranges (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), and ranged from 50 to 73 years. The majority of participants were on an AI at the time of enrolment, which included either anastrozole, letrozole or exemestane, with three studies reporting the average length of time on an AI (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), and ranging from 1.7 to 2.1 years. In <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>, participants commenced the exercise intervention within 12 weeks of being initiated on an AI. For detailed information on inclusion and exclusion criteria for each study, see the <a href="./references#CD012988-sec-0128" title="">Characteristics of included studies</a> table. </p> <p>For the studies that only included participants experiencing AIMSS at baseline, the definition of AIMSS varied widely. Some studies reported their inclusion criteria as incorporating women experiencing any joint symptoms whilst taking an AI (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>), and only a few of these had stipulated a minimum pain score to qualify for inclusion (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). Only one study specified arthralgia/myalgias, which were related to the AI as an inclusion criteria, although they did not report their criteria for this (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>). Only one study reported the exclusion of women with pre‐morbid musculoskeletal conditions such as rheumatoid arthritis (<a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). All of the studies had excluded metastatic disease as per their inclusion and exclusion criteria, but one study reported 16% of their participants (n = 10) as having stage IV disease in the baseline demographics (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). </p> </section> <section id="CD012988-sec-0071"> <h5 class="title">Interventions</h5> <p>The included studies investigated a variety of different exercise programmes. Two studies investigated walking programmes, with one of these being Nordic walking, which utilises walking plus the addition of hand‐held poles (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). The other walking study was a home‐based exercise programme of 150 minutes' walking per week (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). Three studies used a combination of resistance training plus aerobic exercise (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). One study only described their intervention as an "exercise program", without further details available (<a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a> enabled participants who were randomised to the exercise arm to choose between three types of exercises, which included either walking/running, gentle callisthenics, or weak exercise such as going up the stairs. </p> <p>The length of the intervention varied between studies, ranging from 6 weeks to 12 months. The intensity of the exercise intervention was variably reported, with only two of the studies reporting the desired level of exercise intensity. One study aimed for 60% to 70% of maximum heart rate, with no further details given (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). The other study aimed for 60% to 80% of maximum heart rate, based on VO<sub>2</sub> max testing (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>). </p> <p>The majority of studies included a mix of both supervised and home‐based exercise; two studies had supervised components initially (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>), but the remainder of the these studies was unsupervised; two studies had supervised strength training plus home‐based aerobic exercise (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>); one study was completely home‐based (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>); one study used completely supervised exercise in the intervention arm (<a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>); and one study was unclear (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). The majority of studies included at least 150 to 200 minutes of exercise weekly. </p> <p>Three studies reported adherence to the exercise intervention (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a> aimed for four independent Nordic walking sessions each week in weeks 7 to 12 of their intervention, but only 8% of participants were compliant with this. In contrast, 68% to 85% completed one to two independent sessions weekly. In <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>, there was 70% mean attendance at the twice‐per‐week strength‐training sessions, and a mean of 119 minutes of aerobic exercise weekly. The recommended amount of aerobic exercise in this study was 150 minutes a week. Control arms also varied widely, including a waiting list control group (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), unsupervised moderate physical activity (<a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>), written information about exercise in cancer (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>), or no exercise instruction until the end of the study (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>). One study only described the control arm as "usual care" (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), and another did not describe the details of their control arm (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>). </p> </section> </section> <section id="CD012988-sec-0072"> <h4 class="title">Excluded studies</h4> <p>The reasons for exclusions are summarised in <a href="./references#CD012988-sec-0129" title="">Characteristics of excluded studies</a>. We excluded the majority of studies because they either were not RCTs; they had the incorrect participant population (e.g. participants on tamoxifen, rather than aromatase inhibitors, or by including women who had metastatic disease); or they were looking at different outcomes, such as other health‐related quality‐of‐life symptoms, including fatigue or hot flushes, rather than AIMSS. </p> </section> </section> <section id="CD012988-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>We have documented details for the risk of bias of the included studies in the 'Risk of bias' tables, listed in the <a href="./references#CD012988-sec-0128" title="">Characteristics of included studies</a>. We requested additional information from study authors where the risk of bias rating was unclear, and was provided by the following studies: <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>. The 'Risk of bias' summary can be viewed in <a href="#CD012988-fig-0002">Figure 2</a>. </p> <section id="CD012988-sec-0074"> <h4 class="title">Allocation</h4> <p>There were a number of studies that were at high risk of selection bias. We judged one study as high risk of selection bias, because during recruitment, three participants who were randomised to the home‐based walking intervention were inadvertently assigned to the waiting list control, and three participants who were randomised to the waiting list control were inadvertently assigned to the exercise intervention (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). It was unclear whether this was due to inadequate random sequence generation or inadequate allocation concealment, and we judged the study at high risk of both components of selection bias. We judged three studies to be at unclear risk of selection bias since these studies failed to report sufficient information to adequately assess their means of random sequence generation (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). We judged the remaining three studies to have adequate random sequence generation (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>), and were therefore judged to be at low risk of selection bias caused by random sequence generation. </p> <p>Three studies were at high risk of selection bias due to concerns with the allocation concealment in their studies, because allocation of the intervention was not concealed such that investigators and participants could not foresee assignment to the study groups. One study, as described above, reported randomisation errors, and although they did not report the actual cause of the error nor when this became apparent, it may have been because investigators were aware of the allocation (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). The study was therefore judged to be at high risk of selection bias (allocation concealment). Another study was at high risk of selection bias (allocation concealment) as the study did not fully implement allocation concealment due to resource constraints (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). One study did not implement allocation concealment (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>), and was also judged as high risk. We rated the remainder of the studies as having an unclear risk of selection bias (allocation concealment) as they did not describe the method of allocation concealment in enough detail to adequately allow definitive judgement (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). </p> </section> <section id="CD012988-sec-0075"> <h4 class="title">Blinding</h4> <p>None of the included studies reported blinding of participants and personnel. It is not feasible to blind participants to an exercise intervention because of the nature of the intervention. We therefore assessed all included studies as being at high risk of performance bias. None of the studies had blinding of outcome assessment. The majority of outcomes were participant‐reported outcomes, and it was not practical to blind participants to these outcomes in an exercise intervention. Two of our outcomes, overall survival and breast cancer‐specific survival, would not be affected by blinding, but none of the studies in our review measured these outcomes. We assessed all the studies as being at high risk of detection bias. </p> </section> <section id="CD012988-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>Three of seven studies reported that they had analysed data according to the intention‐to‐treat (ITT) principle (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), but only one of these studies had completion of outcome assessments for all randomised participants to enable a judgement of low risk of attrition bias (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). We assessed three studies to be at high risk of attrition bias (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), basing this judgement on disparities in dropout rates between intervention and control group (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), or high dropout rates of greater than 20% (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). We assessed three studies to be at unclear risk of attrition bias due to insufficient information available to make a judgement (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). </p> </section> <section id="CD012988-sec-0077"> <h4 class="title">Selective reporting</h4> <p>We judged two studies as low risk of reporting bias, because either they reported all of their proposed outcomes (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), or only minor outcomes included in the initial trial registration were not reported in the study and these outcomes were not of interest to our review (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). We judged five studies as unclear risk of reporting bias. The reasons for judgement of unclear risk were: in one study, at least one relevant missing unreported outcome amongst a very high number of planned outcomes in the protocol (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>); not enough information being provided on outcomes and study protocol or registration not being available (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>); the protocol being available but not enough information on outcomes provided (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>); or the abstract publication reporting different outcomes to those mentioned in the trial registration, and the trial only being reported in abstract publication (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>). </p> </section> <section id="CD012988-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>Four studies were only reported as abstracts, and therefore were difficult to assess for other sources of bias due to inadequate information, and we rated three of these studies as unclear risk (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). We rated one study, which was also reported in abstract/poster form, as being at high risk of other potential sources of bias, for allowing participants in the intervention arm to choose between three different exercise interventions with a wide range of exercise intensities (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). Three studies were at low risk of other sources of bias (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). </p> <p>We have added two additional domains to be assessed across all studies: adherence and contamination. Studies reported different approaches for measuring adherence. Some studies did not provide this information. Adherence was the level of exercise achieved once the participant had agreed to undertake the intervention. In two studies, participants adhered to the exercise intervention adequately, and both studies were assessed as low risk of bias due to adherence (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). In four studies, risk of bias due to adherence was unclear (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). In the remaining study, adherence to the intervention was so low in the independent sessions during weeks 7 to 12 that we classified it as high risk of bias (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). Two studies reported exercise in the non‐exercising control groups (contamination; <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), and we assessed them as high risk of bias for contamination. Four studies did not report contamination and therefore we judged these studies as unclear risk of bias (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). One study had a minimal increase in baseline activity levels in the control group, and therefore we judged it as low risk of bias for contamination (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). </p> </section> </section> <section id="CD012988-sec-0079"> <h3 class="title" id="CD012988-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD012988-tbl-0001"><b>Summary of findings for the main comparison</b> Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</a> </p> <section id="CD012988-sec-0080"> <h4 class="title">Prevention of symptoms</h4> <p>Only one study investigated the use of exercise in the prevention of AIMSS (<a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). This study was stopped early due to lack of funding, after accruing only 20 of the 120 participants intended for the study. We obtained further results from the study and also the study protocol via author correspondence. <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a> allowed the inclusion of women who were only just commencing their AI medication at the time of enrolment, but baseline characteristics showed that the majority of participants were already taking an AI prior to the study: AI administration 25.6 ± 13.8 months in the intervention arm, and 25.3 months ± 14.2 months in the control arm. Therefore we have included <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a> in the analysis of treatment of symptoms section (outlined below). </p> <section id="CD012988-sec-0081"> <h5 class="title">Pain</h5> <p><a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a> used Brief Pain Index (BPI) scores to assess symptoms of pain. The study reported an increase of one BPI unit between baseline and 12‐month follow‐up, compared to an increase of mean BPI scores of five units in the control group. They did not provide any values. Correspondence with the study authors confirmed that differences in pain scores between groups were not statistically significant. </p> </section> <section id="CD012988-sec-0082"> <h5 class="title">Stiffness</h5> <p><a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a> did not report stiffness as an outcome in the prevention of AIMSS. </p> </section> <section id="CD012988-sec-0083"> <h5 class="title">Grip strength</h5> <p><a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a> reported a trend towards improved grip strength between baseline and six months in the exercise group. Study author correspondence confirmed that the change in grip strength was not statistically significant between groups and they did not provide values. </p> </section> <section id="CD012988-sec-0084"> <h5 class="title">Safety of the intervention</h5> <p>The study did not report this outcome.</p> </section> <section id="CD012988-sec-0085"> <h5 class="title">Incidence of AIMSS</h5> <p>The study did not report this outcome.</p> </section> <section id="CD012988-sec-0086"> <h5 class="title">Persistence and compliance of women continuing to take their AI medication due to the intervention </h5> <p><a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a> collected data on AI adherence relating to preventing AIMSS, but this study has not been published in full, and adherence data were not available. We made contact with <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>, who did not provide data for AI adherence, but confirmed that the difference between groups was not statistically significant. </p> </section> <section id="CD012988-sec-0087"> <h5 class="title">Health‐related quality of life</h5> <section id="CD012988-sec-0088"> <h6 class="title">Overall change in health‐related quality of life</h6> <p>The study did not report this outcome.</p> </section> <section id="CD012988-sec-0089"> <h6 class="title">Overall change in cancer‐specific quality of life</h6> <p>The study did not report this outcome.</p> </section> </section> <section id="CD012988-sec-0090"> <h5 class="title">Breast cancer‐specific survival</h5> <p>The study did not report this outcome.</p> </section> <section id="CD012988-sec-0091"> <h5 class="title">Overall survival</h5> <p>The study did not report this outcome.</p> </section> </section> <section id="CD012988-sec-0092"> <h4 class="title">Treatment of symptoms</h4> <p>Six studies investigated the treatment of AIMSS (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). Two of these studies had specified a minimum pain criteria for eligibility into the study, including either a pain score of at least 3 on a 5‐point scale of joint pain, stiffness or achiness in the past seven days (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), or arthralgia for at least two months that was at least mild in severity (consisting of a score of at least 3 for worst pain on a BPI; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>). One study included women who had described any joint symptoms in the previous 12 months via an amended C‐PET (Checklist for Patients on Hormone Therapy) in clinic (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). One study (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>), listed arthralgias/myalgias as part of their inclusion criteria, and another included women who had been experiencing joint discomfort/stiffness when attempting activities of daily living (<a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). One study reported "any arthralgia level" as one of their inclusion criteria (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). </p> <section id="CD012988-sec-0093"> <h5 class="title">Pain</h5> <p>All of the six studies used participant‐reported outcomes to assess pain symptoms. These included the Visual Analogue Scale (VAS; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), Western Ontario and McMaster Universities Index (WOMAC; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), Arthritis self‐efficacy scale (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>), BPI‐Short Form (BPI‐SF; <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>), BPI (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), Pain Disability Index (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), Pain Self‐Efficacy Questionnaire (PSEQ; <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>) and a Pain Scale (PS; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). </p> <p>We performed a meta‐analysis on the effect of exercise on worst pain. Due to the availability of data, four studies were eligible for inclusion in the meta‐analysis. Three of these studies reported BPI worst pain scores (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), and the remaining study reported WOMAC pain scores and VAS pain scores (<a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). It should be noted that there was a discrepancy in the reporting of results between the two posters published for <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>, with the initial poster (<a href="./references#CD012988-bbs2-0112" title="TajaesuM , TamakiK , NagamineS , KamadaY , UeharaK , ArakakiM , et al. Randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2017;77(4 Suppl):P5‐12‐01. ">Tajaesu 2017</a>), reporting a change of 0.09 points for worst pain at 12 months in the exercise group, and the final results poster reporting a change of 0.03 ± 2.35 points for worst pain in the exercise group. We used the result from the most recent poster/abstract in our analysis. The same study (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), included three types of exercise in the intervention arm, and the participants randomised to the intervention arm were able to choose their exercise group. No details were reported on the number of participants in each exercise group, which ranged from weak exercise (going up the stairs) to strong exercise (120 to 150 minutes per week of walking or running). </p> <p>Due to the different scoring systems used for measuring pain, we performed the analysis using SMD. In the meta‐analysis, <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> used the WOMAC pain subscale and <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> (the Hormones and Physical Exercise (HOPE) trial), used the BPI worst pain scores. The effect of exercise therapies on overall change in worst pain scores using the random‐effects model resulted in an SMD of −0.23 (95% confidence interval (CI) −0.78 to 0.32; I<sup>2</sup> = 79%; 4 studies, 284 participants; very low‐certainty evidence; <a href="#CD012988-fig-0003">Figure 3</a>; <a href="./references#CD012988-fig-0007" title="">Analysis 1.1</a>). There was considerable statistical heterogeneity amongst the studies involved in the meta‐analysis, which is likely to be explained by the wide range of outcome assessment tools used and also the range of exercise interventions utilised between the studies. The results using other models remained the same (fixed‐effect model: SMD −0.29, 95% CI −0.54 to −0.04; HKSJ random‐effects model: SMD −0.23, 95% CI −1.13 to 0.67). We performed a separate analysis using the results from the VAS scale in <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>, which showed similar results (SMD −0.25, CI −0.80 to 0.30; I<sup>2</sup> = 79%; <a href="./references#CD012988-fig-0008" title="">Analysis 1.2</a>; fixed‐effect model: SMD −0.31, 95% CI −0.56 to −0.06). </p> <div class="figure" id="CD012988-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using WOMAC pain subscale for Nyrop 2017" data-id="CD012988-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using WOMAC pain subscale for <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> </p> </div> </div> </div> <p><a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> only reported BPI worst pain using change‐from‐baseline SD, rather than the SD of final values. Due to the potential risk of a change‐from‐baseline SD giving greater weight to the study, as discussed in our <a href="#CD012988-sec-0057">Measures of treatment effect</a>, we also performed an analysis using SD from final values, obtained via study author correspondence. Of note, these data did not use a mixed‐effect model with covariate adjustment as used in the published study results. The results of this analysis were also similar (SMD −0.18, CI −0.63 to 0.26; I<sup>2</sup> = 68%; <a href="./references#CD012988-fig-0009" title="">Analysis 1.3</a>). </p> <p>Only limited results were available for the studies that we did not include in the meta‐analysis. <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a> reported that the exercise intervention did not have a measurable improvement in AIMSS using the post‐intervention, 12‐week SF‐36 pain scores, but did not report actual pain scores. <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a> reported that the intervention group showed a slight improvement in the pain scale, but did not report numerical values. </p> <p>We were unable to determine the effect of exercise on worst pain scores, because we rated the evidence as very uncertain due to serious concerns with the risk of bias, such as lack of blinding, lack of allocation concealment, one study having inadequate random sequence allocation, and concerns about participation adherence to the exercise programme and contamination of the control group. The sample size in the meta‐analysis was small, and therefore there were serious concerns regarding imprecision. There was also statistical heterogeneity between studies, and multiple studies that did not publish their results in full. See the funnel plot in <a href="#CD012988-fig-0004">Figure 4</a> and <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> <div class="figure" id="CD012988-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale for Nyrop 2017" data-id="CD012988-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale for <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> </p> </div> </div> </div> </section> <section id="CD012988-sec-0094"> <h5 class="title">Stiffness</h5> <p>Two studies investigated stiffness as an outcome (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> used the WOMAC index, which incorporates three domains of pain, stiffness and physical function. However, the study authors did not report the stiffness subscale of the WOMAC index, and we were unable to obtain this result via study author correspondence. <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> reported stiffness using a VAS, and also the stiffness subscale of the WOMAC. For both scoring tools, higher scores indicate greater symptom severity. In the study by <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>, involving 53 people, the WOMAC stiffness subscale reported a decrease in mean scores in the intervention arm (unsupervised walking programme) of −0.94 (95% CI −1.78 to −0.11) versus a decrease in mean scores of −0.18 (95% CI −0.94 to 0.57) in the waiting list control arm at the end of the six‐week programme. Our own calculations showed the effect of exercise on stiffness as a mean difference (MD −0.76, 95% CI −1.67 to 0.15; 1 study, 53 people; low‐certainty evidence; <a href="./references#CD012988-fig-0010" title="">Analysis 1.4</a>), using the WOMAC stiffness scale. The VAS stiffness scale reported a change in mean scores of −0.24 (95% CI −1.53 to 1.05) from baseline until the end of the six‐week programme in the intervention arm, versus a change in mean scores of 0.18 (95% CI −1.02 to 1.38) in the control arm. Our own calculations showed the overall change in stiffness scores using the VAS tool as MD −0.42 (95% CI −2.10 to 1.26; 1 study, 53 people; low‐certainty evidence; <a href="./references#CD012988-fig-0010" title="">Analysis 1.4</a>). </p> <p>We rated the evidence for this outcome as low certainty due to concerns with the risk of bias, including inadequate random sequence generation and allocation concealment, plus lack of blinding and attrition bias. The small sample size, with only one study publishing results on this outcome has raised concerns about imprecision. See <a href="./references#CD012988-sec-0128" title="">Characteristics of included studies</a> and <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012988-sec-0095"> <h5 class="title">Grip strength</h5> <p>Two studies investigated grip strength (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> reported no statistical difference in grip strength between the intervention and control groups at the end of the 12‐month intervention period, with mean change from baseline 0.1 (95% CI −0.5 to 0.7) and 0.4 (95% CI −0.2 to 0.9) respectively, P = 0.47. Our calculations showed a MD of 0.30 (95% CI −0.55 to 1.15; 1 study, 83 people; <a href="./references#CD012988-fig-0011" title="">Analysis 1.5</a>). <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a> reported an improvement in both left and right grip strength in the intervention group as compared to the control group, but did not report any numerical values. </p> <p>We rated the certainty of the evidence for this outcome as very low, due to concerns with the risk of bias, including risk of performance bias, detection bias, and contamination in the control arm. One study had not been published in full, and results were not available, so we were unable to incorporate the results for this study in this analysis. The sample size for this analysis was small, and therefore we downgraded the evidence further for imprecision. See <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012988-sec-0096"> <h5 class="title">Safety of the intervention</h5> <p>Four studies involving 331 women addressed safety (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). All four studies examined exercise for treating AIMSS. Three studies (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>), reported no adverse events related to the intervention. <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a> reported two participants dropping out after the first six weeks of supervised exercise in the intervention arm due to longstanding musculoskeletal issues, which were felt to be unrelated to the study intervention. <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a> also reported new pain in two participants, but one of these had newly identified metastases. There was no new lymphoedema in any of the participants in the same study (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). The other three studies (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>), did not report safety of the intervention. We rated the certainty of evidence for this outcome as low, due to concerns with the small sample size of this analysis, and the risk of bias for each study. In particular, none of the studies were blinded to participants or personnel, which we believe may have led to risk of bias for this outcome. See <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012988-sec-0097"> <h5 class="title">Incidence of AIMSS</h5> <p>None of the studies reported this outcome.</p> </section> <section id="CD012988-sec-0098"> <h5 class="title">Persistence and compliance of women continuing to take their AI medication due to the intervention </h5> <p>Two studies assessing exercise for treating AIMSS reported on AI adherence (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). For the two studies that assessed AI adherence secondary to exercise, the random‐effects analysis of the two studies resulted in an odds ratio (OR) of 2.43 (95% CI 0.41 to 14.63; I<sup>2</sup> = 55%; 2 studies, 224 women; very low‐certainty evidence; <a href="./references#CD012988-fig-0012" title="">Analysis 2.1</a>). The event rate of discontinuation was 10 participants in the exercise arm and 12 participants in the control arm. The OR in the fixed‐effect model was 1.78 (95% CI 0.71 to 4.45); and the OR in the HKSJ random‐effects model was 2.43 (95% CI 0 to 271558). Using the HKSJ random‐effects model, the upper confidence interval changed dramatically from 14.63 to 271558. This is due to the fact that we have only two studies for this outcome. The adjustment is done as a function of the exponentiated T value, which in this case is 12.7 and thus it led to a huge change. We note as well that the effects estimate from the two studies is very different (1.24 and 8.42). The interpretation in both cases remains the same: the upper confidence interval is high and there is a big difference in the effect estimated by the two studies. We graded the certainty of evidence for this outcome as very low, due to serious concerns with imprecision as a result of the small sample size and event rate. There were also concerns regarding the risk of bias in each study, and we downgraded the evidence further as multiple studies have not been published in full, leading to a suspicion of publication bias. See <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012988-sec-0099"> <h5 class="title">Health‐related quality of life</h5> <section id="CD012988-sec-0100"> <h6 class="title">Overall change in health‐related quality of life</h6> <p>Two studies (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), reported general health‐related quality of life, in the form of the SF‐36 (<a href="./references#CD012988-bbs2-0104" title="Rand Health Care. 36‐Item Short Form Survey (SF‐36). www.rand.org/health‐care/surveys_tools/mos/36‐item‐short‐form.html. [www.rand.org/health‐care/surveys_tools/mos/36‐item‐short‐form.html] ">Rand Health Care</a>). An additional study (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>), collected data from SF‐36, but did not report them. <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> published quality‐of‐life data in a separate publication (<a href="./references#CD012988-bbs2-0044" title="BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. ">Baglia 2019</a>). There is not a total score for the SF‐36 tool, instead, the subscales can be grouped into a Physical Component Score and a Mental Health Component Score. One study did not give the Physical Component score (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>). Therefore, we analysed the eight subscales within the SF‐36 separately, as these data were available. Using the SF‐36, a higher score indicated better health status. </p> <p>The results using a random‐effects model from the eight subscales included:</p> <p> <ul id="CD012988-list-0011"> <li> <p>role physical (MD 6.15, 95% CI 2.03, 10.26);</p> </li> <li> <p>physical functioning (MD 9.70, 95% CI 1.67 to 17.73; fixed‐effect model MD 7.78, 95% CI 5.02 to 10.54; HKSJ random‐effects model MD 9.7, 95% CI −42.32 to 61.72); </p> </li> <li> <p>bodily pain (MD 7.60, 95% CI 4.51 to 10.70);</p> </li> <li> <p>general health (MD 3.62, 95% CI 0.92 to 6.33)</p> </li> <li> <p>vitality (MD 4.96, 95% CI 2.52 to 7.40);</p> </li> <li> <p>social functioning (MD 4.45, 95% CI 1.33 to 7.58);</p> </li> <li> <p>role emotional (MD 1.88, 95% CI −2.69 to 6.45);</p> </li> <li> <p>and mental health (MD 3.15, 95% 0.57 to 5.73).</p> </li> </ul> </p> <p>All subscale analyses included two studies involving 123 women and very low‐certainty evidence (see <a href="#CD012988-fig-0005">Figure 5</a>). Our analysis does not include the single‐item Change in Health questionnaire, as this was not available from one study (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> (see quality‐of‐life data in <a href="./references#CD012988-bbs2-0044" title="BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. ">Baglia 2019</a>)). <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a> used median values and interquartile ranges for reporting data, and stated that their reasoning for doing this was skewed data. <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>, as reported in <a href="./references#CD012988-bbs2-0044" title="BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. ">Baglia 2019</a>, provided mean values and change score confidence intervals, which we combined with the median scores and final value SDs calculated from <a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>. Ideally, the combination of change score and final value confidence intervals should not be done, as discussed in the <a href="#CD012988-sec-0057">Measures of treatment effect</a> section. The greatest improvements were seen in the physical component scores, with the effect of exercise resulting in improvements in physical functioning and bodily pain, and which may correspond with clinically significant benefits (minimal clinically important improvement (MCII) of 7.1 and 4.9, respectively; <a href="./references#CD012988-bbs2-0114" title="WardMM , GuthrieLC , AlbaMI . Clinically important changes in Short Form 36 Health Survey Scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care &amp; Research2014;66(12):1783‐9. ">Ward 2014</a>). We graded the overall certainty of this evidence as very low, due to concerns with risk of bias for both studies (including concerns with performance bias, detection bias, poor adherence to the intervention in one study, and contamination of the control arm in both studies), a suspicion of publication bias as at least one study investigating this outcome has not been published in full, and also a considerable degree of imprecision with wide confidence intervals and a small sample size for the analysis. See <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> <div class="figure" id="CD012988-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison 2. Secondary outcomes, outcome 2.2: health‐related quality of life" data-id="CD012988-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 2. Secondary outcomes, outcome 2.2: health‐related quality of life </p> </div> </div> </div> <p>We did not assess other aspects of general quality of life, such as fatigue and depression, as part of this review. A number of studies investigated other aspects of quality of life using various participant‐reported outcomes, such as the Centre for Epidemiological Studies Depression Scale (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), the Functional Assessment of Chronic Illness Therapy ‐ Fatigue (FACIT‐F; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), and the Patient Health Questionnaire‐4 (PHQ‐4; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). </p> <p><b>Overall change in cancer‐specific quality of life</b> </p> <p>We added overall change in cancer‐specific quality of life as an additional outcome, after our protocol was published. Our rationale was to try and report health‐related quality of life in a more useful way for the reader, rather than one overall global health‐related quality of life, which we felt would have been an incomplete assessment. Two studies assessed cancer‐specific quality of life with the Functional Assessment of Cancer Therapy ‐ General (FACT‐G) score (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>). <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> published its quality‐of‐life data in a separate publication (<a href="./references#CD012988-bbs2-0044" title="BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. ">Baglia 2019</a>). In the FACT‐G assessment tool, higher scores indicated better quality of life. </p> <p>Our meta‐analysis included quality‐of‐life assessments performed at the end of the exercise intervention in each study, which was after six weeks in <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>, and 12 months in <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>, comprising a total of 136 participants. The effect of exercise resulted in a MD of 4.58 (95% CI −0.61 to 9.78; 2 studies; 136 participants; very low‐certainty evidence; <a href="#CD012988-fig-0006">Figure 6</a>; fixed‐effect model: MD 5.06, 95% CI 1.56 to 8.56; HKSJ random‐effects model: MD 4.58, 95% CI −29.12 to 38.28). The minimal clinically important change (MCID) score for FACT‐G is 5 to 6 points (<a href="./references#CD012988-bbs2-0060" title="EtonDT , CellaD , YostKJ , YountSE , PetermanAH , NeubergDS , et al. A combination of distribution‐and anchor‐based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. Journal of Clinical Epidemiology2004;57(9):898‐910. ">Eton 2004</a>). We graded the certainty of this evidence as very low, due to the small sample size used in this analysis, leading to serious concerns with imprecision, and also concerns with risk of bias for both studies (including one study with high selection bias, and both studies having lack of blinding for the intervention and outcome assessments) and a suspicion of publication bias due to our knowledge of multiple studies not being published in full. See <a href="./full#CD012988-tbl-0001">summary of findings Table for the main comparison</a>. </p> <div class="figure" id="CD012988-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison 2. Secondary outcomes, outcome 2.3: cancer‐specific quality of life" data-id="CD012988-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 2. Secondary outcomes, outcome 2.3: cancer‐specific quality of life </p> </div> </div> </div> </section> </section> <section id="CD012988-sec-0101"> <h5 class="title">Breast cancer‐specific survival</h5> <p>None of the studies reported on breast cancer‐specific survival.</p> </section> <section id="CD012988-sec-0102"> <h5 class="title">Overall survival</h5> <p>None of the studies reported on overall survival.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012988-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012988-sec-0103"></div> <section id="CD012988-sec-0104"> <h3 class="title" id="CD012988-sec-0104">Summary of main results</h3> <p>The primary aim of this Cochrane Review was to investigate exercise therapies for the prevention or treatment of AIMSS in early breast cancer. We included data from seven RCTs with a total of 400 enrolled participants: one study assessed exercise for preventing AIMSS while six studies examined treating AIMSS. The comparator arm of studies was either usual care/information or walking, or the comparator was not reported. There was not enough evidence to determine the effect of exercise on the prevention of AIMSS based on a single study. Overall, the certainty of evidence was very low for multiple outcomes from the studies assessing prevention and treatment of AIMSS, and therefore it is unclear whether exercise has a positive or negative effect on pain, hand strength (grip strength), the number of women continuing to take AI medication, or the quality of life of women on AI medications. The evidence suggests that exercise results in little to no change in stiffness in women suffering from AIMSS, although the certainty of the evidence for this outcome was also low. Importantly, exercise is probably safe, with no harms reported, although this was not reported in four of the seven studies, and the follow‐up interval was short. There were no data available to assess the effect of exercise on survival in this specific setting of postmenopausal women with breast cancer on adjuvant AI with AIMSS. Limited evidence from four studies suggests that exercise therapy resulted in little to no increase in adverse events compared to the comparator arm. No serious adverse events were reported. However safety data should be interpreted with caution given the low‐certainty evidence in this review. There was insufficient evidence to determine the impact of exercise on the incidence of AIMSS due to scarcity of data. </p> </section> <section id="CD012988-sec-0105"> <h3 class="title" id="CD012988-sec-0105">Overall completeness and applicability of evidence</h3> <p>The review included studies with considerable clinical and methodological heterogeneity. The exercise interventions varied considerably. There was variability in the type of exercise intervention and in the frequency and intensity of the exercise therapy (e.g. Nordic walking; resistance and aerobic training; home‐based, self‐directed walking; three grades of exercise chosen by participant preference including a “weak” exercise arm); in the supervision and incorporation of behavioural support (home‐based versus supervised); the duration of the intervention; and the nature of the control arm (usual care; written information; walking). Similar variability in exercise interventions has been noted in other Cochrane Reviews of exercise, including 'Exercise training for advanced lung cancer' (<a href="./references#CD012988-bbs2-0102" title="Peddle‐McIntyreCJ , SinghF , ThomasR , NewtonRU , GalvaoDA , CavalheriV . Exercise training for advanced lung cancer. Cochrane Database of Systematic Reviews2019, Issue 2. [DOI: 10.1002/14651858.CD012685.pub2] ">Peddle‐McIntyre 2019</a>), and 'Exercise for women receiving adjuvant therapy for breast cancer' (<a href="./references#CD012988-bbs2-0068" title="FurmaniakAC , MenigM , MarkesMH . Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD005001.pub3] ">Furmaniak 2016</a>). Limited information about the details of the interventions, and particularly the comparator arms, were available from some of the studies. Due the limitations of the available data, it was not possible to make any definitive conclusions about whether all relevant exercise interventions have been investigated. Due to the paucity of studies available, this review was unable to undertake further subgroup analyses to determine the effect of variations in exercise intensity, the effect of the setting or supervision of the exercise (supervised versus home‐based) or the effect of differing types of exercise (such as aerobic/resistance/combination) on AIMSS. There are undoubtedly other exercise therapies, or variations of these, that could be trialled for AIMSS, but we are unable to determine whether these would affect the body of evidence. </p> <p>Interventions were conducted in a variety of different settings, such as home‐based, outpatient clinic etc. For applicability of the exercise interventions, consideration of the differences in the standard of care of women with early breast cancer would need to be considered in different populations and varying healthcare environments or systems, as these context factors may influence the effect of exercise interventions (<a href="./references#CD012988-bbs2-0073" title="HaweP , ShiellA , RileyT , GoldL . Methods for exploring implementation variation and local context within a cluster randomised community intervention trial. Journal of Epidemiology &amp; Community Health2004;58(9):788‐93. ">Hawe 2004b</a>; <a href="./references#CD012988-bbs2-0108" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>). Similar to the comments in the Cochrane Review, 'Exercise for women receiving adjuvant treatment for breast cancer' (<a href="./references#CD012988-bbs2-0068" title="FurmaniakAC , MenigM , MarkesMH . Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD005001.pub3] ">Furmaniak 2016</a>), the exercise interventions being investigated for the treatment of AIMSS can be considered a complex intervention (<a href="./references#CD012988-bbs2-0072" title='HaweP , ShiellA , RileyT . Complex interventions: how "out of control" can a randomised controlled trial be?. BMJ2004;328(7455):1561‐3. '>Hawe 2004a</a>). The Medical Research Council document 'A Framework for the Development and Evaluation of Randomised Controlled Trials for Complex Interventions' argues that “the greater the difficulty in defining precisely what exactly are the ‘active ingredients’ of an intervention and how they relate to each other, the greater the likelihood that you are dealing with a complex intervention" (<a href="./references#CD012988-bbs2-0091" title="Medical Research Council. A Framework for development for the development and evaluation of randomised controlled trials for complex interventions to improve health. London: Medical Research Council, 2000. ">Medical Research Council 2000</a>). <a href="./references#CD012988-bbs2-0073" title="HaweP , ShiellA , RileyT , GoldL . Methods for exploring implementation variation and local context within a cluster randomised community intervention trial. Journal of Epidemiology &amp; Community Health2004;58(9):788‐93. ">Hawe 2004b</a> propose that for a complex intervention, such as exercise for AIMSS, which requires behavioural change, “the function and process of the intervention should be standardised, not the components themselves" allowing the intervention to be tailored to the local conditions. </p> <p>Women with early breast cancer included in this review did have racial diversity (predominantly white/Asian) however certain racial groups were not adequately represented. Lack of racial diversity was noted in the Cochrane Review of 'Exercise for women receiving adjuvant treatment for breast cancer' (<a href="./references#CD012988-bbs2-0068" title="FurmaniakAC , MenigM , MarkesMH . Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD005001.pub3] ">Furmaniak 2016</a>), who noted the preponderance of white women included in the reviewed trials. The median age of participants diagnosed in the USA with breast cancer is 62 years (SEER database, <a href="./references#CD012988-bbs2-0081" title="HowladerN , NooneAM , KrapchoM , MillerD , BrestA , YuM , et al. Table 1.11 Median age of cancer patients at diagnosis (2012‐2016). SEER Cancer Statistics Review, (1975‐2016). Bethesda, MD: National Cancer Institute., 2019. [ http://seer.cancer.gov/csr/1975_2016/ Accessed on August 6, 2019] ">Howlader 2019</a>). The median age range of participants in the included studies is similar to this, and representative of post‐menopausal breast cancer in high‐income countries. However there were no reported participants included in the reviewed trials who were older than 75 years of age, although reporting of age ranges was poor. In addition, improvements in disease‐free survival outcomes were observed in pre‐menopausal women in the SOFT and TEXT studies, which were two landmark trials that showed the benefit of aromatase inhibitor use in pre‐menopausal women with breast cancer in the adjuvant setting, in combination with ovarian function suppression (<a href="./references#CD012988-bbs2-0065" title="FrancisP , ReganM , FlemingG , LángI , CiruelosE , BelletM , et al. Adjuvant ovarian suppression in premenopausal breast cancer. New England Journal of Medicine2015;372(5):436‐46. ">Francis 2015;</a><a href="./references#CD012988-bbs2-0066" title="FrancisPA , PaganiO , FlemingGF , WalleyBA , ColleoniM , LangI , et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. New England Journal of Medicine2018;379(2):122‐37. ">Francis 2018</a>). In these two trials, 88.7% of women who received ovarian suppression plus exemestane reported musculoskeletal symptoms compared to 69.0% of the women who received tamoxifen alone. Few young post‐menopausal women with AIMSS were included in the studies of our Cochrane Review, likely due to time frames when results from the SOFT and TEXT studies became available (<a href="./references#CD012988-bbs2-0065" title="FrancisP , ReganM , FlemingG , LángI , CiruelosE , BelletM , et al. Adjuvant ovarian suppression in premenopausal breast cancer. New England Journal of Medicine2015;372(5):436‐46. ">Francis 2015</a>; <a href="./references#CD012988-bbs2-0066" title="FrancisPA , PaganiO , FlemingGF , WalleyBA , ColleoniM , LangI , et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. New England Journal of Medicine2018;379(2):122‐37. ">Francis 2018</a>). Women are being increasingly treated with ovarian suppression with AI and into the future, will represent an increasing group of women with AIMSS. These women may potentially have different baseline symptom levels, or responses to exercise interventions that have not yet been assessed. <a href="./references#CD012988-bbs2-0090" title="MaoJJ , StrickerC , BrunerD , XieS , BowmanMA , FarrarJ , et al. Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors. Cancer2009;115(16):3631‐9. ">Mao 2009</a> reported AIMSS appeared to be inversely correlated with time since menopause, raising the possibility that young women with abrupt oestrogen withdrawal may be most at risk of symptoms. </p> <p>The included studies have recruited in highly resourced health economies, which may have resources allowing interventions such as supervised exercise programmes. Hence the studied exercise interventions may not be applicable in all health systems. Rates of adherence or acceptability may not be the same or even feasible in different settings or populations. Post‐menopausal breast cancer interventions should preferably be broadly applicable to older women. <a href="./references#CD012988-bbs2-0086" title="KilariD , Soto‐Perez‐de‐CelisE , MohileSG , AlibhaiSM , PresleyCJ , WildesTM , et al. Designing exercise clinical trials for older adults with cancer: recommendations from 2015 Cancer and Aging Research Group NCI U13 meeting. Journal of Geriatric Oncology2016;7(4):293‐304. ">Kilari 2016</a> recommend that when designing exercise clinical trials for older adults with cancer, the exercise interventions should ideally be cost effective and “not burdensome to the patient/payer/society”.<br/> <br/> Many debilitating symptoms that are characteristic of AIMSS have not been adequately investigated, such as joint stiffness, which only has findings reported from one study; and other outcomes have uncertain evidence. Problematically, there is inconsistent definition of AIMSS, lack of objective outcome measures, and multiple participant‐reported outcomes in the trials to date (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015</a>; <a href="./references#CD012988-bbs2-0098" title="NiravathP . Aromatase inhibitor‐induced arthralgia: a review. Annals of Oncology2013;24(6):1443‐9. ">Niravath 2013</a>), and this lack of consensus limits the interpretation of the degree of completeness of the outcome measures in our review. Multiple outcomes were assessed and it was difficult to combine several of the outcome measures in meta‐analysis. Data reporting was of low quality for some of the included studies, and some important outcome measures were missing and we were unable to obtain them. Similarly, there was considerable heterogeneity in the timing of the outcome measures (6 weeks to 12 months) due to the variation in exercise protocols, and in the length of follow‐up. Differences in the timing of outcome measures between studies may limit comparability and determination of effect size. Duration of follow‐up considerations may be important in determining longer‐term benefits or harms of the exercise intervention. </p> <p>Very few studies investigated the effect of exercise on quality of life in women with AIMSS. Due to the wide range of symptomatology of AIMSS, and the potential severity of symptoms, AIMSS can affect multiple facets of health and well‐being for women. Safety data were not available for many of the studies, although reported adverse event rates do appear minor and of low incidence in the remaining studies. As only limited safety data are available, a degree of caution needs to be observed. Adherence rates to exercise were reported in two studies, and this is important also in investigating the tolerability of a particular exercise intervention, and also potential differences between the interventions. Adherence rates to aromatase inhibitors were only reported in two studies. Continuing adherence to AI treatment would seem to be an important outcome for improvement due to an exercise intervention, so it does appear the evidence body is not complete. Many of the above factors do limit conclusions about the benefits or harms of exercise in women with AIMSS. In addition, as studies included were generally of small size and at risk of bias, caution should be advised in interpretation of this review. </p> </section> <section id="CD012988-sec-0106"> <h3 class="title" id="CD012988-sec-0106">Quality of the evidence</h3> <p>There were only a small number of studies available, and only a small number of participants in most of the studies. The number of participants in the intervention arm ranged from 11 to 80 across all studies. The overall number of participants in each of our outcome assessments was low, which led to downgrading the certainty of evidence for all outcomes due to serious concerns about imprecision. Furthermore, a number of outcomes produced results with wide confidence intervals, where the 95% confidence interval included both no effect and appreciable benefit or harm. One study (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>), included in the analysis, reported results with medians and interquartile ranges rather than means and confidence intervals/standard deviations, due to skewed data. The quality‐of‐life data, in particular, reported very imprecise results with wide confidence intervals. All outcome assessments using results from this study should be viewed with caution, due to the skewed data in their study. </p> <p>Due to the nature of the intervention, blinding of participants and personnel was not possible. The extent to which absence of blinding may have affected the results of each outcome is unclear, but this contributes a high risk of performance bias for each of the included studies. In addition, there was a high risk of detection bias for each of the studies, as the majority of the outcomes were self‐reported, and the remaining outcomes were not blinded to outcome assessors. Multiple studies were at risk of selection bias, with one study reporting mistakes in their random sequence generation, and multiple studies had inadequate allocation concealment. A number of studies had inadequate outcome data and selective reporting of outcomes. We judged that particularly the problems with allocation concealment and random sequence generation could potentially impact the results of these studies to a considerable degree, and therefore we downgraded by at least one point the grading of evidence for all of our outcomes due to serious concerns with the risk of bias of all studies. In addition as studies included were generally of small size and at risk of bias, caution should be advised in interpretation of this review. </p> <p>Because of the heterogeneous nature of the various exercise regimens amongst the studies, we downgraded the certainty of evidence for the worst pain outcome by one point due to moderate statistical heterogeneity. For the remaining outcomes where there was only mild to moderate statistical heterogeneity, we did not downgrade the certainty of the evidence. </p> <p>Four of the seven studies had only been reported in abstract form, and not published in full. Three of these studies reported non‐significant differences in pain between the intervention and control groups, and therefore it is likely that they were not published in full because they were deemed to be negative studies. It is therefore possible that some of our outcomes may have over‐emphasised the benefit of exercise, due to publication bias amongst studies on this topic. A number of other outcomes of interest to this review were assessed by the studies that had not been published in full, and we were unable to obtain the results. The publication of these results may have improved the certainty of evidence in our review across multiple outcomes. </p> </section> <section id="CD012988-sec-0107"> <h3 class="title" id="CD012988-sec-0107">Potential biases in the review process</h3> <p>A strength of this review is the extensive search methods strategy employed, with no language limitation, which we expected would have identified the main studies. However, it should be acknowledged that the searches identified only English language studies, raising the possibility that we missed studies in other languages, with possible publication bias for studies included in our review. Inconsistency in the definitions of AIMSS or exercise therapy may have potentially led to bias in the search strategy for studies. We attempted to account for this by making the search strategy broad. We designed a search strategy with terms for all the generally accepted exercise therapies that have been investigated in the literature, and for all aromatase inhibitors in clinical practice. Two review authors independently reviewed each of the searched studies to assess the risk of bias. </p> <p>We attempted to contact all study authors for further information. Three study authors provided additional information (<a href="./references#CD012988-bbs2-0001" title="FieldsJ , RichardsonA , HopkinsonJ , FenlonD . Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor‐ associated arthralgia: a feasibility study. Journal of Pain and Symptom Management2016;52(4):548‐59. ">Fields 2016</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0005" title="SanmugarajahJ , AllanS , BagchiR , LaaksoEL . Can a supervised exercise program compared to usual care prevent aromatase inhibitor‐induced musculoskeletal pain in women with breast cancer?. Cancer Research2017;77(4 Suppl):P5‐12‐02. ">Sanmugarajah 2017</a>). We were either unable to contact four study authors or they could not provide additional information at the time of our data collection (<a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>; <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a>; <a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>; <a href="./references#CD012988-bbs2-0007" title="VaradarajanR , HelmE , ArnoldC , Huelsenbeck‐DillL , Ingraham‐LoprestoB , SonaadS , et al. Abstract P5‐12‐04: directed exercise intervention in breast cancer patients with arthralgias receiving aromatase inhibitors: a randomized pilot study. Cancer Research2016;76(4 Supplement):P5‐12‐04‐P5‐12‐04. ">Varadarajan 2016</a>). A language barrier may have played a role in our inability to make contact with the authors of the Japanese study (<a href="./references#CD012988-bbs2-0006" title="TamakiK , TakaesuM , NagamineS , TerukinaS , KamadaY , UeharaK , et al. Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia. Cancer Research2018;78(4 Suppl):P6‐11‐01. ">Tamaki 2018</a>). Three authors providing additional data increased the available data for analysis. A limitation of our analysis of exercise for prevention or treatment of AIMSS are unavailable data, and this introduces selection bias into our review; we had to exclude certain outcomes from the meta‐analysis due to our inability to obtain further requested data. </p> <p>Due to resource constraints, we did not systematically evaluate the strengths and weaknesses of the measurement instruments. However as per comments in the above section, there are enormous discrepancies in subjective and objective outcome measures used to assess AIMSS (<a href="./references#CD012988-bbs2-0076" title="HershmanDL , LoprinziC , SchneiderBP . Symptoms: aromatase inhibitor induced arthralgias. In: GanzPA editor(s). Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing, 2015:89‐100. ">Hershman 2015;</a><a href="./references#CD012988-bbs2-0098" title="NiravathP . Aromatase inhibitor‐induced arthralgia: a review. Annals of Oncology2013;24(6):1443‐9. ">Niravath 2013</a>), and this is hence a limitation of our review, as outcome results will need to be interpreted in the context of heterogeneity of measurement of outcomes. </p> </section> <section id="CD012988-sec-0108"> <h3 class="title" id="CD012988-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>This is the first Cochrane Review of exercise for prevention or management of AIMSS. Other review evidence (systematic reviews and meta‐analyses) were systematically reviewed. Our search strategy was broad to catch all potentially relevant papers. In agreement, although at an earlier search date than ours, a systematic review of systematic reviews (<a href="./references#CD012988-bbs2-0087" title="KimTH , KangJW , LeeTH . Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis. Maturitas2018;118:29‐37. ">Kim 2018</a>), identified the same three systematic reviews that included exercise (<a href="./references#CD012988-bbs2-0096" title="NahmN , MeeS , MarxG . Efficacy of management strategies for aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review. Asia‐Pacific Journal of Clinical Oncology2018;14(6):374‐82. ">Nahm 2018</a>; <a href="./references#CD012988-bbs2-0106" title="RobertsK , RickettK , GreerR , WoodwardN . Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis. Critical Reviews in Oncology/Hematology2017;111:66‐80. ">Roberts 2017</a>; <a href="./references#CD012988-bbs2-0115" title="YangGS , KimHJ , GriffithKA , ZhuS , DorseySG , RennCL . Interventions for the treatment of aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review and meta‐analysis. Cancer Nursing2017;40(4):E26‐e41. ">Yang 2017</a>). However, in this Cochrane Review, we excluded systematic reviews of acupuncture alone for AIMSS. </p> <p>Several of the authors involved in this review were also previously involved in a review entitled 'Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis' (<a href="./references#CD012988-bbs2-0106" title="RobertsK , RickettK , GreerR , WoodwardN . Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis. Critical Reviews in Oncology/Hematology2017;111:66‐80. ">Roberts 2017</a>). This review considered all clinical trials, both prospective and retrospective, including RCTs, cohort and case‐control studies and preventative trials of interventions for AIMSS; included all pharmacological, non‐pharmacological (including exercise) and complementary and alternative medicine (CAM) interventions. <a href="./references#CD012988-bbs2-0106" title="RobertsK , RickettK , GreerR , WoodwardN . Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis. Critical Reviews in Oncology/Hematology2017;111:66‐80. ">Roberts 2017</a> considered only English language publications, identified three RCTs (<a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015</a>; <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0003" title="LohrischCA , McKenzieD , TruongP , JespersonD , GelmonKA , PremjiS , et al. A randomized trial of exercise versus control for musculoskeletal symptoms from adjuvant anastrozole (A) for postmenopausal early breast cancer (PEBC). Journal of Clinical Oncology2011;29(15 Suppl):636. ">Lohrisch 2011</a>), and grouped physical therapies narratively. They performed meta‐analysis on two RCTs of exercise (<a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>; <a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015</a>), and the overall mean difference in the worst BPI using a random‐effects model was −0.29 (95% CI −3.32 to 2.75), with significant between‐study heterogeneity. <a href="./references#CD012988-bbs2-0106" title="RobertsK , RickettK , GreerR , WoodwardN . Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis. Critical Reviews in Oncology/Hematology2017;111:66‐80. ">Roberts 2017</a> is not directly comparable to this Cochrane Review, as due to paucity of data, they included non‐randomised data and the scope of interventions was broader. They determined evidence quality to be poor overall, but it was not graded. <a href="./references#CD012988-bbs2-0106" title="RobertsK , RickettK , GreerR , WoodwardN . Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: a systematic review and meta‐analysis. Critical Reviews in Oncology/Hematology2017;111:66‐80. ">Roberts 2017</a> did not undertake any reporting or analysis of stiffness, health‐related quality of life or adherence outcomes. No adverse events were reported in agreement with this Cochrane Review. </p> <p>Yang and colleagues conducted a review entitled 'Interventions for the treatment of aromatase inhibitor associated arthralgia in breast cancer survivors. A systematic review and meta‐analysis' (<a href="./references#CD012988-bbs2-0115" title="YangGS , KimHJ , GriffithKA , ZhuS , DorseySG , RennCL . Interventions for the treatment of aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review and meta‐analysis. Cancer Nursing2017;40(4):E26‐e41. ">Yang 2017</a>). They included all studies that were RCTs and “quasi‐experimental design”. The primary outcome was pain, described as a mean score, and assessed by BPI at the end time point of the intervention. They included a subgroup analysis of three studies of exercise in the meta‐analysis: two were RCTs (<a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015;</a><a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>), and one was a pre‐test post‐test study (<a href="./references#CD012988-bbs2-0012" title="DeNysschenCA , BurtonH , AdemuyiwaF , LevineE , TetewskyS , O'ConnorT . Exercise intervention in breast cancer patients with aromatase inhibitor‐associated arthralgia: a pilot study. European Journal of Cancer Care2014;23(4):493‐501. ">DeNysschen 2014</a>). Physical exercise was reported to show “no significant effect on pain, although they had a trend to decreasing joint pain” (SMD −0.562, 95% CI −1.499 to 0.375). This subgroup meta‐analysis was consistent with our review. However they undertook no reporting or analysis of stiffness or health‐related quality‐of‐life outcomes, and did not report any adverse events, in contrast to this Cochrane Review. </p> <p>Nahm and colleagues performed a systematic review entitled 'Efficacy of management strategies for aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review' (<a href="./references#CD012988-bbs2-0096" title="NahmN , MeeS , MarxG . Efficacy of management strategies for aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review. Asia‐Pacific Journal of Clinical Oncology2018;14(6):374‐82. ">Nahm 2018</a>). They identified one RCT of exercise (<a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015</a>), and did not perform a meta‐analysis. As this systematic review included all management interventions for AIMSS and included non‐randomised studies, it is not directly comparable. </p> <p>The most recent review, <a href="./references#CD012988-bbs2-0087" title="KimTH , KangJW , LeeTH . Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis. Maturitas2018;118:29‐37. ">Kim 2018</a>, was entitled 'Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis'. This was a systematic review of eligible systematic reviews, which were subjected to evidence mapping, and the RCTs included in the reviews were handsearched for network meta‐analysis. The search strategy therefore differs, as does the statistical methodology, and the included studies to our Cochrane Review. <a href="./references#CD012988-bbs2-0087" title="KimTH , KangJW , LeeTH . Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis. Maturitas2018;118:29‐37. ">Kim 2018</a>'s effectiveness outcome was mean and standard deviation of BPI. Two of the six RCTs included in the network meta‐analysis were exercise studies (<a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015;</a><a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a>). In contrast to our review, <a href="./references#CD012988-bbs2-0087" title="KimTH , KangJW , LeeTH . Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis. Maturitas2018;118:29‐37. ">Kim 2018</a> did not combine these but compared them separately to waiting list control, with the review stating, “aerobic exercise… significantly improved pain severity scores” for the study by <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> (MD −0.80, 95% CI −1.33 to −0.016) in the abstract of the article. There was no combined meta‐analysis of the data from <a href="./references#CD012988-bbs2-0002" title="AremH , SorkinM , CartmelB , FiellinM , CapozzaS , HarriganM , et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship2016;10(4):654‐62. BagliaML , LinIH , CartmelB , SanftT , LigibelJ , HershmanDL , et al. Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor‐induced arthralgias in breast cancer survivors. Cancer2019;125(13):2262‐71. Crespo‐BosqueM , BrownC , CartmelB , HarriganM , IrwinM , NeogiT . Pain and sensitization in women with aromatase inhibitor‐associated arthralgias. Arthritis and Rheumatology2016;68:2524‐6. IrwinM . Exercise in the management of arthralgia. Asia‐Pacific Journal of Clinical Oncology2016;12:69. IrwinM , CartmelB , GrossC , ErcolanoE , LiF , YaoX , et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. Journal of Clinical Oncology2015;33(10):1104‐11. IrwinML , CartmelB , GrossC , ErcolanoE , FiellinM , CapozzaS , et al. Randomized trial of exercise vs. usual care on aromatase inhibitor‐associated arthralgias in women with breast cancer: the Hormones and Physical Exercise (HOPE) study. Cancer Research2013;73(24 Suppl):S3‐03. PrintzC . Exercise helps ease joint pain for women with breast cancer. Cancer2014;120(8):1133. ThomasGA , CartmelBR , HarriganM , FiellinM , CapozzaS , ZhouY , et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity2017;25(2):346‐51. ">Irwin 2015</a> with <a href="./references#CD012988-bbs2-0064" title="FieldsJ . A feasibility study of a Nordic walking intervention for women experiencing aromatase inhibitor associated arthralgia [Doctoral Thesis]. Southampton, U.K.: University of Southampton, 2015. ">Fields 2015</a> of Nordic walking. The MD of BPI for Nordic walking versus control was −1.58 (95% CI −3.21 to 0.05). In agreement with our review, <a href="./references#CD012988-bbs2-0087" title="KimTH , KangJW , LeeTH . Therapeutic options for aromatase inhibitor‐associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta‐analysis. Maturitas2018;118:29‐37. ">Kim 2018</a> concluded adverse event reporting to be poor, and as a result of this, they did not undertake network meta‐analysis of adverse events. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012988-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD012988-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD012988-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using WOMAC pain subscale for Nyrop 2017" data-id="CD012988-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using WOMAC pain subscale for <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale for Nyrop 2017" data-id="CD012988-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison 1. Primary outcomes, outcome 1.1: overall change in worst pain, using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale for <a href="./references#CD012988-bbs2-0004" title="NyropK , CallahanL , ClevelandR , ArbeevaL , HackneyB , MussH . Randomized controlled trial of a home‐based walking program to reduce moderate to severe aromatase inhibitor‐associated arthralgia in breast cancer survivors. Oncologist2017;22(10):1238‐48. ">Nyrop 2017</a> </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 2. Secondary outcomes, outcome 2.2: health‐related quality of life" data-id="CD012988-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison 2. Secondary outcomes, outcome 2.2: health‐related quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 2. Secondary outcomes, outcome 2.3: cancer‐specific quality of life" data-id="CD012988-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison 2. Secondary outcomes, outcome 2.3: cancer‐specific quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes, Outcome 1 Overall change in worst pain, using WOMAC pain subscale for Nyrop 2017." data-id="CD012988-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes, Outcome 1 Overall change in worst pain, using WOMAC pain subscale for Nyrop 2017. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes, Outcome 2 Overall change in worst pain with VAS scale for Nyrop 2017." data-id="CD012988-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes, Outcome 2 Overall change in worst pain with VAS scale for Nyrop 2017. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes, Outcome 3 Overall change in worst pain using final values standard deviations for Irwin 2015." data-id="CD012988-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes, Outcome 3 Overall change in worst pain using final values standard deviations for Irwin 2015. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes, Outcome 4 Overall change in stiffness scores." data-id="CD012988-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes, Outcome 4 Overall change in stiffness scores.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes, Outcome 5 Overall change in grip strength." data-id="CD012988-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes, Outcome 5 Overall change in grip strength.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes, Outcome 1 Persistence and compliance with aromatase inhibitors." data-id="CD012988-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes, Outcome 1 Persistence and compliance with aromatase inhibitors. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes, Outcome 2 Health‐related quality of life." data-id="CD012988-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes, Outcome 2 Health‐related quality of life.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012988-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/urn:x-wiley:14651858:media:CD012988:CD012988-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_t/tCD012988-CMP-002-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes, Outcome 3 Cancer‐specific quality of life." data-id="CD012988-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes, Outcome 3 Cancer‐specific quality of life.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/media/CDSR/CD012988/image_n/nCD012988-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012988-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS)<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> exercise therapies<br/> <b>Comparison:</b> standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI) with the use of exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in worst pain scores</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.23 SD lower<br/> (0.78 lower to 0.32 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>284<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in worst pain scores. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in stiffness scores</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The effect in this single study ranged from MD 0.76 points lower (1.67 lower to 0.15 higher) to MD 0.42 points lower (2.10 lower to 1.26 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that exercise therapies result in little to no difference in overall change in stiffness scores. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in grip strength</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 points higher<br/> (0.55 lower to 1.15 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>6,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in grip strength. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in health‐related quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We could not calculate total score. Effect within subscales of HR‐QoL ranged from MD 1.88 points higher (2.69 lower to 6.45 higher) to 9.70 points higher (1.67 higher to 17.73 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in health‐related quality of life. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall change in cancer‐specific quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.58 points higher<br/> (0.61 lower to 9.78 higher) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,11,12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on overall change in disease‐specific quality of life. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects secondary to the intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Nil adverse events in either arm.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>331<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that exercise therapies are low risk, with no adverse events reported across four studies </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adherence to aromatase inhibitors</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 2.43<br/> (0.41 to 14.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>224<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>3,13,14</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of exercise therapies on adherence to aromatase inhibitors. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>AIMSS:</b> aromatase inhibitor‐induced musculoskeletal symptoms; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation; <b>SMD:</b> standardised mean difference; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias concerns with each study, including lack of blinding of participants/personnel and outcome assessors. There were serious concerns regarding random sequence allocation and allocation concealment in one study. High risk of attrition bias in three studies. Concerns regarding exercise contamination in the control arm in two studies. Downgraded 1 point.<br/> <sup>2</sup>Significant statistical heterogeneity, I<sup>2</sup> = 79%, resulting in downgrading 1 point for inconsistency.<br/> <sup>3</sup>Multiple studies only written in abstract form, without pursuing full publication, including studies that had unpublished results relevant to this outcome. Strong suspicion of publication bias, and therefore downgraded 1 point.<br/> <sup>4</sup>Downgraded 1 point for imprecision, due to a number of factors: sample sizes were too small to determine an accurate result; the width of the confidence interval is consistent with both benefit and harm; and one of the studies included skewed data.<br/> <sup>5</sup>High risk of bias for this study, due to serious concerns with random sequence generation and allocation concealment, and also the lack of blinding of participants/personnel and outcome assessors. In addition, high risk of attrition bias. Selective reporting bias for one study for this outcome, which did not report results. Downgraded 1 point.<br/> <sup>6</sup>Small number of participants and null effect and appreciable harm and benefit included in the confidence interval. Downgraded 1 point.<br/> <sup>7</sup>Two studies did not report grip‐strength results, as only published in abstract form. Downgraded 1 point for publication bias.<br/> <sup>8</sup>Downgraded 1 point for risk of bias, due to inability to blind participants/personnel to the intervention, and lack of blinding for outcome assessors. Concerns regarding incomplete outcome data and exercise contamination in the control arm.<br/> <sup>9</sup>Imprecision was present, due to wide range of confidence intervals, a sample size that was too small to provide accurate results, and inclusion of one study that had skewed data. Downgraded 1 point.<br/> <sup>10</sup>Downgraded 1 point for risk of bias. Lack of blinding for participants/personnel, and inadequate allocation concealment. Judged as high risk of attrition bias in one study, and concerns regarding exercise contamination in the control arms of both studies. Poor adherence to exercise in one study.<br/> <sup>11</sup>Downgraded 1 point for imprecision, due to small sample size and wide confidence intervals, which included both the null effect and appreciable benefit.<br/> <sup>12</sup>Risk of bias concerns with each study, including lack of blinding of participants/personnel and outcome assessors. There were serious concerns regarding random sequence allocation and allocation concealment in one study. High risk of attrition bias in both studies. In addition, concerns regarding exercise contamination in the control arm in one study. Downgraded 1 point.<br/> <sup>13</sup>Downgraded 1 point for imprecision, because the sample size was small, and the event rate low.<br/> <sup>14</sup>Downgraded 1 point due to high risk of bias with each study, including high risk of attrition bias in both studies, and one study only being published in abstract form so limited data available. It is unclear how much lack of blinding of participants and personnel may have impacted on this outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Exercise therapies compared to standard care for the management of aromatase inhibitor‐induced musculoskeletal symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/full#CD012988-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012988-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall change in worst pain, using WOMAC pain subscale for Nyrop 2017 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.78, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Overall change in worst pain with VAS scale for Nyrop 2017 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.80, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall change in worst pain using final values standard deviations for Irwin 2015 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.63, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Overall change in stiffness scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Stiffness as per WOMAC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.67, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Stiffness as per VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐2.10, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Overall change in grip strength <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.55, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012988-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Persistence and compliance with aromatase inhibitors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.43 [0.41, 14.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Health‐related quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Role physical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.15 [2.03, 10.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Physical functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.70 [1.67, 17.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Bodily pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.60 [4.51, 10.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 General health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.62 [0.92, 6.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Vitality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.96 [2.52, 7.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Social functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.45 [1.33, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Role emotional</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [‐2.69, 6.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [0.57, 5.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Cancer‐specific quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.58 [‐0.61, 9.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012988.pub2/references#CD012988-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012988.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012988-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012988-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012988-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD012988-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD012988-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012988-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012988-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012988\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012988\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012988\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012988\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012988.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012988.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012988.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012988.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012988.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729644660"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012988.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729644663"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012988.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee1ec7f5c9377',t:'MTc0MDcyOTY0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 